The QualityStocks Daily Friday, February 17th, 2023

Today's Top 3 Investment Newsletters

The Stock Dork(IBIO) $1.4800 +97.28%

Small Caps Daily Alerts(OKYO) $3.7400 +62.96%

StockEarnings(AMCX) $27.1300 +32.34%

The QualityStocks Daily Stock List

Sonasoft Corp. (SSFT)

QualityStocks, MoneyTV, Stock News Now, PoliticsAndMyPortfolio, Wallstreetbuzz,, Penny Stock Circle, Fortune Stock Alerts, 1-2-3 Stock Alerts, TheOTCInvestor, StockRunway, Pumps and Dumps, PennyStockSpy and 007 Stock Chat reported earlier on Sonasoft Corp. (SSFT), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Sonasoft Corp. is a leader in inventive Artificial Intelligence (AI) and data management solutions. The Company delivers value-added AI–driven solutions targeting larger enterprises. It combines wide-ranging expertise in Data Engineering, Big Data Analytics, and AI consulting. As the experts in Big Data Analytics, Sonasoft transforms clients’ raw data into a useful commodity. Founded in 2002 and OTCQB-listed, Sonasoft is based in San Jose, California.

In essence, Sonasoft provides solutions that preserve, manage, as well as create competitive advantage from data. Sonasoft helps companies realize considerable returns on their data-asset investments. It helps companies preserve and manage their data assets and sustain business continuity through its SonaVault and SonaSQL archiving, backup, recovery, migration, replication, and eDiscovery software and services.

The Company has its Sonasoft NuGene enterprise AI platform. NuGene has the ability to go beyond correlation of data points to identify causal relationships among them. It delivers higher quality, higher confidence predictions and recommendations. The NuGene platform helps customers discover risks and explore mitigation options, forecast future scenarios, model future actions, make better-informed decisions, and automate important business processes.

Additionally, Sonasoft has its SonaVault. It archives email, chats, file share platforms, social media sites, and an array of other business applications. SonaVault comes with robust eDiscovery tools that can also seamlessly connect with Exterro, the leading full-spectrum eDiscovery platform, when the legal team requires more.

The design of SonaVault is to meet operational excellence, Storage Email Management, Mailbox Email Management, and regulatory email compliance needs. These include Sarbanes Oxley (SOX), Health Insurance Portability (HIPAA), and National Association of Securities Dealers (NASD), now known as the Financial Industry Regulatory Authority (FINRA).

Sonasoft Corp. (SSFT), closed Friday's trading session at $0.03, up 294.7368%, on 20,917,867 volume. The average volume for the last 3 months is 112,229 and the stock's 52-week low/high is $0.0065/$0.05.

flooidCX Corp. (FLCX)

QualityStocks, Penny Picks and Damn Good Penny Picks reported earlier on flooidCX Corp. (FLCX), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

flooidCX Corp. is a customer experience solutions business. The Company provides customer care and feedback solutions. Global experts, flooidCX helps bridge the customer care and feedback gap between companies and consumers through unifying communications and collaborations over one seamless platform. flooidCX is based in Oakville, Ontario and the Company’s shares trade on the OTC Markets’ OTCQB.

flooidCX improves customer retention and increases new sales via upsells and cross-selling. The Company’s solutions include Resolution1 and GripeVine. Resolution1 helps businesses to never lose track of customer feedback or customer inquiries. It enables businesses to take back control of the customer conversation and lead with an “end to end” cloud based solution.

Resolution1 works right out of the box. It helps any business improve their customer support operations across manifold departments and agents. The design of its platform is to grow and scale to a client’s needs, whether they are a start-up, SME, or Enterprise based business.

GripeVine is a pay-wall free social sentiment-gathering platform for Customer Feedback. GripeVine provides companies an opportunity to create positive outcomes in after-sales customer interactions. It is the “go to” Consumer-to-Business platform for numerous Fortune 1000 brands.

GripeVine has its proprietary customer care and feedback management platform. Customers can rate their experiences, good or bad, offer compliments, or seek resolution through interacting directly with business agents.

flooidCX Corp. (FLCX), closed Friday's trading session at $1.85, up 85%, on 112,229 volume. The average volume for the last 3 months is 2.331M and the stock's 52-week low/high is $0.0825/$2.88.

Voip-Pal.Com Inc. (VPLM)

QualityStocks,, Mega Stock Pick, Pumps and Dumps, HotOTC, Stock Rich, Pick Alerts, BullRally, Buzz Stocks, Clutch Investments, CoolPennyStocks, equities Canada, Google Alerts, Monster OTC, Penny Stock Fever, StockEgg, MajorPennyStocks, Breaking Bulls, Bullish Stock Picks, Wallstreetbuzz,, VC Stock Marketing, UndiscoveredEquities,, TooNiceStocks, TheSUBWAY, FeedBlitz, Stockoutlaws, Penny Invest, HotStockProfits, SmallCapAllStars, MarketClub Analysis, Mega Stock Picks, Stock Twiter, NYC Marketing Inc, Best Stock Picks, Stock Traders Chat, WallstreetsHotteststocks, Premiumstockpicks, Promotion Stock Secrets, Stock Fortune Teller, SmallCapVoice and StockHotTips reported earlier on Voip-Pal.Com Inc. (VPLM), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Voip-Pal.Com Inc. (OTCQB: VPLM) is a broadband VoIP telecom firm which develops and owns a portfolio of VoIP services.

The firm has its headquarters in Waco, Texas and was incorporated in September 1997 by Emil Malak and Francis Assif. Prior to its name change in September 2006, the firm was known as VOIP It operates as part of the telecom services industry, under the communication services sector. The firm serves commercial and residential clients around the globe.

The company is focused on creating virtual bridges which span international communications. Its objective is to connect the world through the delivery of cost-efficient technology that enables high-volume voice, text and digital multi-media communications.

The enterprise provides routing and classification of communications geographically distributed nodes and over a number of networks; uninterrupted transmissions in the course of endpoint changes; mobile gateways; improved emergency calling support services; lawful interception of such communications; and billing and metering, including the resale of white label telecommunication services. It also offers a transactional billing platform that’s tailored to the air mile and points business. This is in addition to providing antivirus applications for smartphones. The enterprise serves wholesale and retail carriers, network suppliers and telephony system vendors.

The firm is focused on monetizing its VoIP (Voice over Internet Protocol) technology, which will help bring in revenues into the firm as well as attract additional investors. This is in addition to extending the firm’s consumer reach and global reach, which will bolster its growth and create revenue for its shareholders.

Voip-Pal.Com Inc. (VPLM), closed Friday's trading session at $0.0789, up 25.2381%, on 2,331,231 volume. The average volume for the last 3 months is 1.829M and the stock's 52-week low/high is $0.01/$0.1144.

Muscle Maker (GRIL)

QualityStocks, StockMarketWatch, ProTrader, BUYINS.NET, AwesomeStocks, StockStreetWire, Penny Stock, MarketClub Analysis and InvestorPlace reported earlier on Muscle Maker (GRIL), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Muscle Maker Inc. (NASDAQ: GRIL) (FRA: 0XJ) is a firm that operates and owns the franchises Healthy Joe and Muscle Maker Grill restaurants, under the Muscle Maker Grill brand.

The firm has its headquarters in League City, Texas and was founded in 1995 by Rodney C. Silva. It operates in the consumer discretionary sector, in the fast casual restaurant segment. The firm is a part of the fast food and quick service restaurants industry and serves consumers in the U.S.

The enterprise’s fast-casual restaurant specializes in the preparation of protein-based, made-to-order lean and healthy inspired foods which include fruit smoothies, protein shakes, salads and sides, flat bread, hamburgers, pastas, seafood and chicken. In addition to this, it also operates under the Gourmet Sandwich, Salad Vibes, Wrap It Up, Burger Joe’s, Bowl’s Deep, Muscle Maker Burger Bar and the Meal Plan AF brand names. This is in addition to providing meal preps or meal plans to customers through their site.

The company’s menu includes items with all-natural chicken and grass-fed steak, in addition to options that satisfy different dietary preferences, from a gluten-free diet and a low-carb diet to a vegetarian diet.

As of December 31, 2020, the company had 16 franchises and 16 owned restaurants located in Kuwait and in the U.S. The firm recently acquired Pokemoto, which is its 2nd acquisition of 2021. Pokemoto has 13 locations in 4 states in the U.S. (Georgia, Massachusetts, Rhode Island and Connecticut), and is planning on opening half a dozen more in the near future. The acquisition will allow Muscle Maker to expand into a new market, which will encourage investments into the firm.

Muscle Maker (GRIL), closed Friday's trading session at $1.39, up 21.9298%, on 1,828,858 volume. The average volume for the last 3 months is 2,471 and the stock's 52-week low/high is $0.30/$1.40.

Sernova (SEOVF)

MarketBeat, QualityStocks and TradersPro reported earlier on Sernova (SEOVF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Sernova Corp. (OTCQB: SEOVF) (TSE: SVA) (ETR: PSH) (FRA: PSH) is a clinical-stage regenerative medicine therapeutics firm that is focused on developing and commercializing proprietary technologies for chronic illnesses.

The firm has its headquarters in London, Canada and was incorporated in 1998, on August 19th. It operates as part of the biotechnology industry, under the healthcare sector. The firm serves consumers around the globe.

The company is committed to clinically advancing products for chronic illnesses, using therapeutic cells transplanted into an implanted medical device, forming a natural environment promoting long-term function of the cells. It is party to a research collaboration with AgeX Therapeutics Inc., involving the generation of immune-protected therapeutic cells. The company is also party to a research agreement with the University of Miami, centered on advancing the development of the Cell Pouch cell therapy platform.

The enterprise’s therapeutics technologies include a scalable and implantable medical device known as the Cell Pouch. This device has been designed to create a vascularized tissue environment for the transplantation and engraftment of therapeutic cells, which then release proteins and/or hormones for the long-term treatment of various serious chronic diseases, such as type 1 diabetes, hemophilia, and thyroid disease.

The firm recently announced that great progress had been made in its collaboration with Evotec SE on its iPSC-derived islet-like clusters in combination with Sernova’s implantable Cell Pouch™ device. This positions them well to become the best-in-class cell therapy in the diabetic field, which will greatly benefit patients with the said indication while also bringing in more investments into the companies.

Sernova (SEOVF), closed Friday's trading session at $0.696, off by 7.2%, on 2,471 volume. The average volume for the last 3 months is 500 and the stock's 52-week low/high is $0.50/$1.37.

Marimaca Copper (MARIF)

We reported earlier on Marimaca Copper (MARIF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Marimaca Copper Corp (OTCQX: MARIF) (TSE: MARI) (FRA: E2E1) is a copper exploration firm focused on acquiring, exploring for and developing mineral properties and projects in Chile and the United States.

The firm has its headquarters in Toronto, Canada and was incorporated in 2004, on September 22nd by Alan J. Stephens and Michael D. Philpot. Prior to its name change in May 2020, the firm was known as Coro Mining Corp. It operates as part of the copper industry, under the basic materials sector. The firm serves consumers in Chile.

The company’s vision is to explore and develop new sources of copper to supply an increasing global demand. It primarily explores for copper, iron ore, gold, and other base and precious metals. The company operates through the Chile and Canada geographical segments.

The enterprise’s flagship project is the Marimaca Copper project located in the Antofagasta Region of Chile. The Marimaca Project is a low-risk project, with substantial exploration potential. It consists of a set of claims (the 1-23 Claims), properties owned and optioned by the firm, combined with the adjacent La Atomica and Atahualpa claims, over which the firm has the right to explore and exploit resources and where intensive exploration activities have been focused; this larger area is referred to as the Marimaca District.

The firm, which recently announced results from its final diamond drilling campaign, remains focused on value creation. This will greatly benefit its shareholders while also bolstering its overall growth.

Marimaca Copper (MARIF), closed Friday's trading session at $2.663, up 13.3191%, on 500 volume. The average volume for the last 3 months is 200 and the stock's 52-week low/high is $1.51/$3.51.

Extendicare (EXETF)

MarketBeat reported earlier on Extendicare (EXETF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Extendicare Inc. (OTC: EXETF) (TSE: EXE) (LON: OS9E) (FRA: 5XE) is a holding firm engaged in the provision of nursing care, home health care, retirement living, and management and consulting services for seniors.

The firm has its headquarters in Markham, Canada and was incorporated in 1968, on August 7th by John MacKay and Harold Livergant. It operates as part of the medical care facilities industry, under the healthcare sector. The firm serves consumers in Canada.

The company operates through the Long-Term Care, Retirement Living, Home Health Care, and Other Services business segments. The Long-Term Care segment represents the long-term care centers the company owns and operates in the country. The Retirement Living segment includes acquired retirement communities, and newly constructed and opened communities. The Home Health Care segment offers more than 9 million hours of home health care services annually in Ontario, Alberta, Manitoba and Nova Scotia. The Other Services segment provides contract services, consulting and group purchasing services to third parties.

The enterprise provides long term care (LTC) services; retirement living services; and home health care services, which include nursing care, occupational, physical and speech therapy, and assistance with daily activities. It operates a network of 119 LTC homes and retirement communities, as well as home health care operations under the Extendicare, Esprit Lifestyle Communities, ParaMed, Extendicare Assist, and SGP Purchasing Partner Network brands.

The firm, which is scheduled to release its latest financial results soon, remains committed to delivering quality care throughout the health continuum to meet the needs of a growing seniors’ population.

Extendicare (EXETF), closed Friday's trading session at $5.02899, up 1.4318%, on 200 volume. The average volume for the last 3 months is 22,747 and the stock's 52-week low/high is $4.707263/$6.33.

Imugene (IUGNF)

We reported earlier on Imugene (IUGNF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Imugene Limited (OTC: IUGNF) (ASX: IMU) is a clinical-stage immune-oncology firm that is focused on the development of a range of immunotherapies to activate the immune system of cancer patients to treat and eradicate tumors in Australia.

The firm has its headquarters in Sydney, Australia and was incorporated in 1986, on May 30th. It operates as part of the biotechnology industry, under the healthcare sector. The firm serves consumers in Australia and Europe.

The company is party to a research collaboration with Celularity Inc., involving the development of a combination of Imugene's CD19 oncolytic virus technology and Celularity's CD19 targeting allogeneic chimeric antigen receptor T-cell therapy as well as CyCART-19 for the treatment of solid tumors. It is also party to a strategic collaboration with Eureka Therapeutics Inc.

The enterprise’s product pipeline is comprised of HER-Vaxx, a HER2-positive cancer vaccine that stimulates a polyclonal antibody response against HER2/neu receptors in gastric and breast cancer. Its HER-Vaxx is in Phase 1b/2 study evaluating its effectiveness in treating gastric cancer. It is also focused on the development of PD1-Vaxx, a cancer vaccine that aims to induce the body to produce polyclonal antibodies that block PD-1 signaling; and CF33, a combination of genomic sequences from various vaccinia virus strains to generate potent virus remedies.

The company remains focused on advancing and strengthening its clinical pipeline in an effort to meet its goals. This will benefit patients with a range of indications while also generating value for its shareholders.

Imugene (IUGNF), closed Friday's trading session at $0.103, up 3.4137%, on 22,747 volume. The average volume for the last 3 months is 14,448 and the stock's 52-week low/high is $0.0837/$0.222.

Psycheceutical Bioscience Inc. (BWVI)

Promotion Stock Secrets, Information Solutions Group, Wallstreetbuzz, SmallCapVoice, QualityStocks and PennyStocks24 reported earlier on Psycheceutical Bioscience Inc. (BWVI), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Psycheceutical Bioscience (OTC: BWVI), a bioscience company dedicated to developing cutting-edge technologies for the next generation of mental health treatments, has entered into an exclusive agreement with iNGENū Pty Ltd., an Australian-based contract research organization. The agreement calls for iNGENū to conduct ​two human ​clinical trials of BWVI’s patented NeuroDirect(TM) ketamine topical ​in Australia. The first, a phase 1 trial, is designed to study 20 people and evaluate the safety, tolerability and pharmacokinetics of a single dose of NeuroDirect ketamine; the second, a phase 2 trial, is designed to study 115 participants diagnosed with post-traumatic stress disorder (“PTSD”) to evaluate the effectiveness of NeuroDirect ketamine on treating their symptoms. “We’re thrilled to have partnered with iNGENū as we move our proprietary delivery technology into human clinical trials,” said Psycheceutical Bioscience CEO Chad Harman in the press release. “iNGENū is an industry-leading, full-service CRO providing end-to-end services for companies like ours developing psychedelic drugs. Together, we’re committed to discovering new psychedelic therapies for mental health disorders and central nervous system diseases. We’re eager to engage in this next phase of the development of ​​​​our NeuroDirect delivery system, which we’re designing to solve the issues with side effects that most psychedelic drug development companies face, while at the same time developing lifesaving mental health treatments.​​”

To view the full press release, visit

About Psycheceutical Bioscience Inc.

Psycheceutical Bioscience is developing cutting-edge technologies to advance the safe and effective delivery of psychedelic pharmaceutical medicines. Powered by a team of FDA drug-development veterans, biotechnology experts and top minds in the psychedelic industry, Psycheceutical is on a mission to commercialize its precision-dosing technologies to provide affordable, life-saving treatments to anyone suffering from mental health disorders or central nervous system diseases. For more information about the company, please visit

Psycheceutical Bioscience Inc. (BWVI), closed Friday's trading session at $0.1715, up 13.5762%, on 14,448 volume. The average volume for the last 3 months is 8.575M and the stock's 52-week low/high is $0.11/$0.4499.

Newmont Corporation (NEM)

MarketClub Analysis, InvestorPlace, The Street, Kiplinger Today, Schaeffer's, StocksEarning, Market Report, The Online Investor, MarketBeat, Barchart, StreetAuthority Daily, Daily Trade Alert, TopStockAnalysts, StreetInsider, Top Pros' Top Picks, Louis Navellier, Streetwise Reports, Daily Wealth, SmarTrend Newsletters, Investopedia, Zacks, Money Morning, Uncommon Wisdom, TradingMarkets, PROFIT CONFIDENTIAL,, The Growth Stock Wire, Trades Of The Day, Wealth Daily, TheStockAdvisor, The Wealth Report,, QualityStocks, ProfitableTrading, Wall Street Grand, Cabot Wealth, Investing Signal, TheStockAdvisors, The Best Newsletters, Dividend Opportunities, Market Intelligence Center Alert, All about trends, Trading Markets, National Inflation Association, Wyatt Investment Research, Energy and Capital, Market FN, InvestmentHouse, Darwin Investing Network, AllPennyStocks, Stockhouse, Money and Markets, InvestorsObserver Team, Wall Street Daily, Daily Markets, OTC Stock Pick, Buttonwood Research, Investment House, Street Insider, TradingAuthority Daily, Wall Street Greek, The Tycoon Report, Trading Tips, StreetAlerts, Investors Alley, Investiv, Dynamic Wealth Report, Investing Futures, Wealth Insider Alert, Market Authority, The Stock Enthusiast, Investment U, Trading Concepts,, Daily Profit, Short Term Wealth, Trader Jack, 24/7 Trader, StockTwits, FNNO Newsletters and MarketWatch reported earlier on Newmont Corporation (NEM), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

We are at the International Trading Estate, located near Heathrow Airport in London. The year is 1983; the date is Nov. 26. While this may seem like any other day, one of the biggest heists in United Kingdom history is about to take place.

On this day, £26 million ($33 million) worth of bullion, cash and diamonds was looted from a Brink’s-Mat operated warehouse. In today’s money, this equates to more than £93 million ($112 million) worth of assets.

Brink’s-Mat was a joint venture between MAT Transport, a firm based in London, and Brink’s, a U.S. security firm. The Brink’s-Mat robbers’ initial objective was to steal £3.2 million ($3.85 million) in cash, but they instead ran off with three tons of gold bullion. This made it the biggest score in British history.

The stolen bullion was Johnson Matthey Bankers Limited property, which sold its bank in 1984 after incurring staggering losses.

It is believed that six robbers took part in the heist; however, only two men were convicted. A huge chunk of the stolen gold was never recovered.

This bold heist was recently acted out in a new BBC One series, “The Gold,” by Neil Forsyth. The Scottish author, journalist and television writer has written and created various shows, including “Guilt, Bob Servant” and “Eric, Ernie and Me.

The six-part series starts us off with six men clad in balaclavas breaking into the secure Brink’s-Mat storage facility near the airport. From there, we are taken through the events that transpired on that fateful day. We see the robbers split up and begin looting the premises.

Throughout the series, law enforcement officers remain in hot pursuit of the criminals, with DCI Brian Boyce leading the manhunt. This character is played by Hugh Bonneville, best known as the Earl of Grantham, Robert Crawlaw of “Downton Abbey.” The only female detective in the squad, Detective Jennings, is played by Charlotte Spencer while Jack Lowden plays Kenneth Noye, one of the robbers who took part in this daring heist.

This isn’t the first time a film based on the robbery has been written. In 1992, a film called “Fool’s Gold” with Sean Bean portraying McAvoy, was released.

Micky McAvoy, one of the six robbers, was sentenced to 25 years in prison for armed robbery in 1984. Later in January 1995, he was ordered by the High Court to pay £27,488,299 ($33 million). This made him responsible for the total sum stolen.

A documentary on the “Crime and Investigation” UK network released in 2010 also featured this robbery.

Gold has fascinated many and been the target of daring heists over the years, but the current crop of industry players, including Newmont Corporation (NYSE: NEM) (TSX: NGT), have evolved, and it would be hard for such blatant acts of criminality to happen today.

Newmont Corporation (NEM), closed Friday's trading session at $45.42, off by 0.937841%, on 8,575,160 volume. The average volume for the last 3 months is 9.841M and the stock's 52-week low/high is $37.45/$86.37.

QuantumScape Corp. (QS)

InvestorPlace, Schaeffer's, StocksEarning, MarketClub Analysis, The Street, The Online Investor, MarketBeat, QualityStocks, Daily Trade Alert, Top Pros' Top Picks, TipRanks, StockEarnings, wyatt research newsletter, Atomic Trades, Trades Of The Day, CNBC Breaking News, Cabot Wealth and BUYINS.NET reported earlier on QuantumScape Corp. (QS), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

As the quest for achieving zero emissions intensifies, electric cars will account for almost 50% of total new vehicle sales globally by 2035, as per Goldman Sachs Research. According to Kota Yuzawa, a strategist for equity research at Goldman Sachs, the rising use of self-driving cars and electrified vehicles would cause a significant change in the automotive sector between the years 2020 through 2030.

As regulations for the environment get tighter and electric vehicle technology advances, the auto sector’s growth won’t slow down. The transition to electric vehicles is predicted to happen more quickly.

Governments in nations all around the world are shifting their focus to electrification and sustainable energy initiatives to reduce emissions while they embrace net-zero goals in the upcoming decades. The United States, whose economy is the largest, along with Canada and Britain as well as the 27-member European Union seek to achieve net-zero emissions by 2050, while China, which comes in second in terms of economy after the U.S., hopes to do so by a decade later. The United Arab Emirates and Saudi Arabia both want to become carbon neutral by 2050 and 2060, respectively.

Goldman Sachs predicts that electric vehicle sales will increase by 32% yearly during this decade, and the electric vehicle revenues will rise from $1 billion to $110 billion.

The report stated that the electric vehicle battery market, which can make up approximately 40% of a vehicle’s price, is consolidating. As per Goldman Sachs, the leading five manufacturers on the battery manufacturers’ list controlled more than 80% of the market across the globe in 2020, whereas the leading five car producers controlled just approximately 40% of the market worldwide.

According to the research, battery manufacturers now have more negotiating leverage, which helps them increase profits. Unfortunately, the government policies in place will alter the supplier networks, with nations such as the U.S. emphasizing local production of materials and pushing the local manufacturing of electric vehicles and their batteries.

The United States Inflation Reduction Act (IRA) encourages the purchase of electric vehicles and provides several tax benefits on renewable energy sources such as solar, wind and hydropower. This framework forbids companies from using the Chinese battery supply chain for exporting batteries to the United States, according to Goldman Sachs.

According to the investment bank, their analysts find strong indications that the IRA formal announcement set to be made in March 2023 will provide comparative advantages to manufacturers that, going forward, are pushing for domestic production of electric vehicles, batteries and electric vehicle materials in the United States. With all these favorable policies and initiatives in place, manufacturers such as QuantumScape Corp. (NYSE: QS) have all the motivation they need to scale up their operations.

QuantumScape Corp. (QS), closed Friday's trading session at $10.31, up 5.0968%, on 9,841,093 volume. The average volume for the last 3 months is 5,051 and the stock's 52-week low/high is $5.11/$22.21.

Quarterhill (QTRHF)

QualityStocks and InvestorPlace reported earlier on Quarterhill (QTRHF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Quarterhill Inc. (OTCQX: QTRHF) (TSE: QTRH) (FRA: WJL) is a diversified holding firm that operates in intelligent transportation system and intellectual property licensing industries globally.

The firm has its headquarters in Toronto, Canada and was incorporated in 1992, on May 14th by Hatim Zaghloul and Michel Tewfik Fattouche. Prior to its name change in June 2017, the firm was known as Wi-LAN Inc. It operates as part of the communication equipment industry, under the technology sector. The firm serves consumers around the globe.

The enterprise operates through the Licensing and Intelligent Transportation Systems segments. Its Licensing segment includes patents relating to wireless communications, semiconductor manufacturing and packaging technologies, wired connectivity, memory interface technologies, computer gaming, automotive applications, enhanced image processing, intelligent personal assistant technologies, non-volatile Flash memory, DRAM and other memory technologies, streaming video technologies, and semiconductor analog circuitry technologies. On the other hand, the Intelligent Systems segment offers international road dynamics products and services, such as automated truck weigh stations, red light and speed enforcement systems; traffic management and safety systems; toll road systems and equipment. It also offers VectorSense, a tire sensor suite; Vehicle Information-In-Motion, a traffic intelligence system; integrated traffic control systems; permanent and portable slow speed weigh-in-motion systems; vehicle and axle detection equipment; portable wheel load scales; traffic data collection products; and automated vehicle identification services and equipment, and other hardware and software products and offerings for the intelligent transportation systems industry. This segment serves clients through direct salespeople, distributors, agents, contractors, and systems integrators.

The company recently entered into a contract with Electronic Transaction Consultants LLC to implement and operate an electronic toll system integration services for the I-680 Express Lanes. This move will not only generate additional revenues for the company but also extend its consumer reach greatly.

Quarterhill (QTRHF), closed Friday's trading session at $1.435, off by 1.51%, on 5,051 volume. The average volume for the last 3 months is 14,745 and the stock's 52-week low/high is $1.05/$2.04.

The QualityStocks Company Corner

Lexaria Bioscience Corp. (NASDAQ: LEXX)

The QualityStocks Daily Newsletter would like to spotlight Lexaria Bioscience Corp. (NASDAQ: LEXX).

Lexaria Bioscience Corp. (NASDAQ: LEXX), a global innovator in drug delivery platforms, recently announcedits 28th granted patent worldwide and the first granted patent fromits sixth patent family, titled Transdermal And/or Dermal Deliveryof Lipophilic Active Agents. “The Canadian patent #3,093,414 is forimproved compositions and methods for transdermal and dermaldelivery of cannabinoids, including cannabidiol (‘CBD’) andtetrahydrocannabinol (‘THC’), all established on the company’spatented DehydraTECH technology,” a recent article reads. “InLexaria’s 2018 study, DehydraTECH-CBD demonstrated almost a 1,900%increase in CBD permeability through human skin compared to acontrol formulation that was devoid of any commercial penetrationenhancements. When pitted against the best-performing commercialpenetration enhancer, DehydraTECH-CBD still proceeded to be 225%more effective at penetration, making it the fastest for absorptioninto the epidermis, dermis and through the skin.”

To view the full article, visit

Lexaria Bioscience Corp. (NASDAQ: LEXX) is a global innovator in drug delivery platforms. The company’s patented technology, DehydraTECH™, improves the way active pharmaceutical ingredients (APIs) enter the bloodstream by promoting healthier oral ingestion methods and increasing the effectiveness of fat-soluble active molecules. DehydraTECH promotes fast-acting, less expensive and more effective oral drug delivery and has been thoroughly evaluated through in vivo, in vitro and human clinical testing.

DehydraTECH is covered by 21 issued and more than 50 pending patents in over 40 countries around the world. Lexaria’s first patent was issued by the U.S. Patent and Trademark Office in October 2016 (US 9,474,725 B1), providing 20 years of patent protection expiring June 2034. Multiple patents have been awarded since then and are expected in the future.

Lexaria has a collaborative research agreement with the National Research Council (NRC), the Canadian government’s premier research and technology organization. The company has filed for patent protection for specific delivery of nicotine, vitamins, NSAIDs, testosterone, estrogen, cannabinoids, terpenes, PDE5 inhibitors (with brand names like Viagra), tobacco and more.

Lexaria began developing DehydraTECH in 2014 and has since continued to strengthen and broaden the technology. The company has no plans to create or sell Lexaria-branded products containing controlled substances. Instead, Lexaria licenses its technology to other companies around the world to offer consumers the best possible performance across an array of ingestible product formats.

The company’s technology is best thought of as an additional layer that providers of consumer supplements, prescription and non-prescription drugs, nicotine and CBD products can utilize to improve the effectiveness of their own existing or planned new offerings. Lexaria has licensed DehydraTECH to multiple companies, including a world-leading tobacco producer for the research and development of smokeless, oral-based nicotine products, and for use in industries that produce cannabinoid beverages, edibles and oral products.

DehydraTECH is suitable for use with a wide range of product formats including pharmaceuticals, nutraceuticals, consumer packaged goods and over-the-counter capsules, pills, tablets and oral suspensions.

DehydraTECH Technology

Lexaria’s DehydraTECH is designed specifically for formulating and delivering lipophilic (fat-soluble) drugs and active ingredients. DehydraTECH increases their effectiveness and improves the way active pharmaceutical ingredients enter the bloodstream. The major benefits to a subject ingesting a DehydraTECH-enabled drug or consumer product can be summarized by the following:

  • Speeds up delivery – the effects of the product are felt by the subject in just minutes.
  • Increases bioavailability – the technology is much more effective at delivering a drug or product into the bloodstream.
  • Increases brain absorption – animal testing suggests significant improvement in the quantity of drug delivered across the blood-brain barrier.
  • Improves drug potency – more of the ingested product is made available to the body, so lower doses are required to achieve the desired effect.
  • Reduces drug administration cost – lower doses mean lower overall drug costs.
  • Masks unwanted taste – the technology eliminates or reduces the need for sweeteners.

Lexaria has demonstrated in animal studies a propensity for DehydraTECH technology to elevate the quantity of drug delivered across the blood-brain barrier by as much as 1,900 percent, initiating additional new patent applications and opening possibilities for improved drug delivery.

Since 2016, DehydraTECH has repeatedly demonstrated, with cannabinoids and nicotine, the ability to increase bio-absorption by up to five to 10 times, reduce time of onset from one to two hours to just minutes, and mask unwanted tastes. The technology is to be further evaluated for additional orally administered bioactive molecules, including antivirals, cannabinoids, vitamins, non-steroidal anti-inflammatory drugs (NSAIDs) and nicotine.

Market Outlook

Lexaria’s ongoing research and development efforts are mainly focused on development of product candidates across several key segments:

  • Oral Cannabinoids – a market estimated to be worth $18.4 billion in 2021 and expected to reach $46.2 billion by 2025.
  • Antivirals – an estimated $52.1 billion market in 2021 that’s expected to grow to $66.7 billion by 2025.
  • Oral Mucosal Nicotine – smokeless tobacco products, a $13.6 billion market in 2018, is forecast to grow at 7.2 percent annually through 2025.
  • Human Hormones – estrogen and testosterone replacement therapies represented a $21.9 billion market in 2019, with a forecast CAGR of 7.7 percent through 2027.
  • Ibuprofen and Naproxen – NSAID sales totaled $15.6 billion globally in 2019 and are projected to reach $24.4 billion by 2027.
  • Vitamin D3 – the global market size was $1.1 billion in 2021, growing at 7 percent per year and expected to reach $1.7 billion in 2026.

Management Team

Chris Bunka is Chairman and CEO of Lexaria Bioscience Corp. He is a serial entrepreneur who has been involved in several private and public companies since the late 1980s. He has extensive experience in the capital markets, corporate governance, mergers and acquisitions, as well as corporate finance. He is named as an inventor on multiple patent innovations.

John Docherty, M.Sc., is the President of Lexaria. He is a pharmacologist and toxicologist, and a specialist in the development of drug delivery technologies. He is the former president and COO of Helix BioPharma Corp. (TSX: HBP). He is named as an inventor on multiple issued and pending patents.

Greg Downey is Lexaria’s CFO. He has more than 35 years of diverse financial experience in the mining, oil and gas, manufacturing, and construction industries, and in the public sector. He served for eight years as CFO for several public companies and has provided business advisory and financial accounting services to many large organizations.

Gregg Smith is a strategic advisor to Lexaria. He is a founder and private investor with Evolution VC Partners. He is a member of the Sand Hill Angels and held previous investment banking roles with Cowen and Company and Bank of America Merrill Lynch.

Dr. Philip Ainslie serves as a scientific and medical advisor to Lexaria. He is co-director for the Centre for Heart, Lung and Vascular Health, Canada. He is also Research Chair in Cerebrovascular Physiology and Professor at the School of Health and Exercise Sciences, Faculty of Health and Social Development at the University of British Columbia.

Lexaria Bioscience Corp. (LEXX), closed Friday's trading session at $3.0397, up 2.6926%, on 14,745 volume. The average volume for the last 3 months is 79,313 and the stock's 52-week low/high is $1.80/$4.83.

Recent News

MetAlert Inc. (OTC: MLRT)

The QualityStocks Daily Newsletter would like to spotlight MetAlert Inc. (OTC: MLRT).

Health oversight agencies anticipate that, during the next decade,a growing number of people living into old age will increase theneed for caregiver services for patients with a decline incognitive function and an increase in confusion

California-based MetAlert is a pioneer in developing wearable,unobtrusive technology that helps caregivers track the whereaboutsof patients with cognitive decline and who may be prone to becominglost if they wander

The company is also preparing to roll out an expansion of itsflagship product that will have the capacity to serve as a tech hubfor its product as well as other wearable health monitoring deviceswith which it can communicate to collect their data for medicalservices

Such devices can help eliminate the need for patients to routinelyvisit medical offices to monitor their health data, where they mayrisk exposure to other people who may endanger their health, as wasmade clear during the height of the COVID pandemic

Last fall, the newest report on age and health of the World HealthOrganization (“WHO”) stated that the number of people aged 60 yearsand older outnumbered children younger than 5 years in 2020 andprojected that between 2015 and 2050, the proportion of the world'spopulation over 60 years will nearly double from 12 percent to 22percent ( The growth of the population of people entering into old age,and the rising ratio of older populations to younger caregivinggenerations, has taken on new importance for societies working tomanage attendant costs and other concerns. Wearable tracking andhealth monitoring device developer MetAlert (OTC: MLRT) has developed its flagship technology as an accessible solutionfor those dealing with one area of concern — declining cognitivecapability and the potential for harmful or even deadly confusion.

MetAlert Inc. (OTC: MLRT) is a pioneer in location sensitive health monitoring devices (estimated $47 billion industry in 2021) and wearable technology products (industry forecast to reach $174 billion by 2030).

With over 20 years of experience and an extensive patent portfolio (30+), MetAlert is a leader for consumers/patients afflicted with Alzheimer’s, dementia, and autism (ADA). This market represents approximately 2.9% of the world’s population (approximately 34 million people in 24 developed countries). Due to specific behaviors (problems with memory, adversity to wearing unknown items, etc.) of consumers/patients in this market segment, traditional products, such as an iPhone or Fitbit, are not a practical solution. This has created a significant market with very few competitors for MetAlert.

MetAlert and its subsidiaries are engaged in designing, developing, manufacturing, distributing, and selling products and services in GPS/BLE wearable technology, personal location, wandering assistive technology, and health data collection and monitoring. The company offers a global end-to-end hardware, software, and connectivity solution, in addition to developing two-way tracking technologies, which seamlessly integrate with consumer products and enterprise applications.

Using its award-winning, patented GPS SmartSole® as a hub for collecting and transmitting data to the cloud in real-time, MetAlert is expanding its value proposition to consumers and increasing its revenue per user (RPU) while creating the largest database of health statistics for ADA consumers/patients. MetAlert generates revenue from product sales, recurring subscriptions, intellectual property (IP) licensing, and professional services. The company has international distributors servicing customers in over 35 countries and is an approved U.S. military government contractor. Its customers include public health authorities and municipalities, emergency and law enforcement, private schools, assisted living facilities, NGOs, small business enterprises, senior care homes and consumers.

The company is headquartered in Los Angeles, California, with a sales office in London, England, and distributors across the globe.


  • GPS SmartSoles® HUB (launched Q4 2022) is a GPS/BLE-equipped insole that allows remote monitoring, data collection, and encrypted data transmission to the cloud.
    • Telehealth (available Q4 2022) allows access remotely to doctors and other health professionals on an as-needed basis. This service will also function as the prescribing doctor once Medicare reimbursement codes are established.
    • Concierge (available Q4 2022) provides 24/7/365 enhanced emergency response that coordinates with all relevant parties to quickly detect false alarms and escalate response as needed.
    • Bluetooth Enabled Devices (available Q1 2023) include third-party devices that collect vitals and other health data and connect with the GPS Smartsoles® HUB.
    • Artificial Intelligence (available Q1 2023) software will evaluate the Teradata of health information identifying trends and respond to preestablished alert thresholds.
  • Take-Along Tracker is a small GPS tracking device – less than three inches long – that works with 4G cellular service and will have the same “HUB” functionality as the GPS Smartsoles®. This versatile and affordable mini tracker boasts super long battery life, with up to 14 days of operation per charge.
  • RoomMate™ is a wall-mounted alert system that detects and alerts caregivers about patient behavior that could lead to falls and injuries. The system features 3D infrared and wall-mounted sensors, eliminating the need for any other physical installation or wearables. RoomMate™ offers patient privacy by design. Images are not stored, but all actions are logged. It’s a unique solution for looking after patients without intruding on their personal space.

Market Outlook

According to Grand View Research (Patient Monitoring Devices Market Size & Share Report, 2030), the global patient monitoring devices market size was valued at $47.0 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 7.8% from 2022 to 2030. The expansion of the industry can be attributed to the rise in demand for monitoring devices used to measure, distribute, record, and display a variety of biometric data, including blood pressure, temperature, and blood oxygen saturation level.

The growing number of chronic disorders, such as diabetes, stroke, and kidney disease, are driving the demand for patient monitoring devices. For instance, according to the World Health Organization (WHO), about 422 million people globally have diabetes. Likewise, the number of asthma and chronic obstructive pulmonary disease patients (COPD) is increasing rapidly.

According to the WHO, around 235 million people suffer from asthma. As a result, peak flow meters, which are used to gauge respiration rate, are increasingly used. The market for patient monitoring devices is driven by the simplicity with which it is handled, transported, and remotely accessible. Major market players are engaging in a variety of tactics to expand the industry, including partnerships, cooperation, innovation, launches, and mergers.

During the COVID-19 outbreak, social segregation and quarantining procedures were put into place worldwide. Many people avoided regular hospital visits as a result. Many people now need routine home temperature and oxygen level monitoring to maintain track of their health, thereby demanding monitoring devices at home.

Various government programs are supporting the pandemic outbreak. The FDA has granted Emergency Use Authorizations (EUAs) for a few wearables and patient monitoring devices to improve access to medicines, monitor patients more closely, and lessen the risk of SARS-CoV-2 exposure to medical professionals during the COVID-19 pandemic.

The growing popularity of wearable and remote patient monitoring devices is another factor fueling the market’s expansion. By fusing clinical symptomology with vital indicators, wearable technology helps in the diagnosis of many chronic diseases. Thus, there has been a dramatic rise in the usage of wearable technology to combat COVID-19.

The wearable medical device market is anticipated to reach $174.48 Billion by 2030, expanding at a 27.1% CAGR during the forecast period (2022-2030), according to Market Research Future.

MetAlert identifies the total addressable market for its wearable patient monitoring tech for those with Alzheimer’s, dementia, and autism at more than 34 million potential patients in North America, Europe, South Africa, and Asia.

Management Team

Patrick E. Bertagna is Founder, CEO and Chairman at MetAlert. He began his career in apparel sales in 1983 and was promoted to national sales manager within two years. In 1986, he founded his first company importing apparel from Europe and selling to U.S. retailers from JCPenney to Neiman Marcus. He has founded several technology and apparel companies, including MetAlert in 2002, which he took public in 2008. He attended Cal State University Northridge with a business major and a psychology minor.

Louis Rosenbaum is COO of MetAlert. He co-founded Global Trek Xploration and was an initial investor in MetAlert. He has successfully started companies in multiple industries, including apparel, environmental services, and the music industry, achieving annual revenues in the multi-millions of dollars. He previously was president of Elements, a women’s apparel company, and of Advanced Environmental Services.

Alex McKean is CFO at MetAlert. He is also the CFO of Encore Brands Inc., a position he has held since 2009. He has held positions as Controller and VP of Finance at 24:7 Film and, Director of FP&A/SVP at Franchise Mortgage Acceptance Company, Corporate Accounting Manager/Treasurer of Polygram Filmed Entertainment and Assistant Treasurer/Controller for State Street Bank. He holds an International MBA from Thunderbird School of Global Management and undergraduate degrees in business and political science from Trinity University.

MetAlert Inc. (OTC: MLRT), closed Friday's trading session at $0.12675, up 1.4%, on 79,313 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $4.83/$.

Recent News

FuelPositive Corp. (TSX.V: NHHH) (OTC: NHHHF)

The QualityStocks Daily Newsletter would like to spotlight FuelPositive Corp. (NHHHF).

FuelPositive (TSX.V: NHHH) (OTCQB: NHHHF) today announced that it commenced system testing on its on-farm,containerized green ammonia production system. The company istesting its resilience to extreme outdoor weather conditions inanticipation of deployment in Manitoba, Canada. Per the update, thefully climatized containerized modules continue to operateefficiently under winter conditions. “FuelPositive has successfullybuilt our containerized modules as fully climatized systems,capable of working in extreme temperatures, ranging from minus 50 Cto plus 45 C. The units are temperature controlled and built to thestrictest hazardous area classifications with redundant monitoring.Our systems are engineered to run without any operator interventionor operator input,” FuelPositive COO Nelson Leite stated in thenews release.

To view the full press release, visit

FuelPositive Corp. (TSX.V: NHHH) (OTC: NHHHF) is a growth stage company focused on licensing, partnership and acquisition opportunities building upon various technological achievements. The company is committed to providing commercially viable and sustainable clean energy solutions, including carbon-free ammonia (NH3), for use across a broad spectrum of industries and applications.

FuelPositive is headquartered in Toronto, Canada.

Hydrogen Economy Problems and FuelPositive’s Carbon-Free Technology

The hydrogen economy is currently facing many challenges. Traditional NH3 manufacturing exists on a massive scale, but centralized facilities result in some of the world’s most concentrated CO2 emissions. In total, an estimated 200 million metric tonnes of NH3 are consumed each year, with greater than 80% utilized by the agricultural sector. NH3 is also being positioned as a viable alternative to fossil fuels.

FuelPositive’s flagship carbon-free ammonia technology provides an innovative solution to these environmental concerns. Developed by Dr. Ibrahim Dincer and his team, the company’s platform allows for the in-situ production of NH3 in an entirely sustainable manner, using only water, air and sustainable electricity.

The production of hydrogen is energy intensive, but it is just one variable hindering the growth of the hydrogen economy. Other hurdles include:

  • Storage – The storage of hydrogen by compression or liquification are both cost prohibitive and unsustainable.
  • Distribution – The distribution network for effective hydrogen deployment has yet to be developed, as the extreme high-pressure distribution requirements to transport hydrogen would result in enormous infrastructure costs.
  • End Use – R&D on the transportation-related end use applications for hydrogen is in its infancy, but almost any vehicle on the road today can be easily converted to run on NH3 at a considerably lower cost per mile traveled when compared to traditional fossil fuels.

A key benefit of FuelPositive’s patent-pending, first-of-its-kind carbon-free NH3 technology is its flexibility. The process allows for small, medium or large-scale production of NH3 on location, minimizing or even eliminating the challenges and volatility associated with storage and transportation to end use. As such, with an appropriately sized FuelPositive system and access to renewable energy, the end use applications for the company’s platform are nearly infinite.

Manufacturing Partnership

On May 19, 2021, FuelPositive announced its selection of National Compressed Air Canada Ltd. (“NCA”) to undertake manufacturing of the company’s Phase 2 hydrogen-ammonia synthesizer commercial prototype systems for carbon-free ammonia production.

In a news release detailing the partnership, FuelPositive CEO Ian Clifford noted, “This critical milestone for FuelPositive will confirm the broad application potential for our technology and is the backbone of our Carbon-Free Hydrogen-NH3 offering. Partnering with the knowledgeable and experienced team at NCA on this commercialization project will bring our development-stage program to life.”

Global Ammonia Market Outlook

The global ammonia market was valued at $52.71 billion in 2017 and is forecast to reach $81.42 billion by 2025, growing at a CAGR of 5.59%, according to data from Fior Markets (

The agricultural industry consumes more than 80% of global NH3. Smaller percentages can be attributed to the waste, water treatment, refrigerants, antiseptic, textile, mining and pharmaceutical industries.

One of the most polluting industries on the planet consists of conventional agribusinesses. These polluters are responsible for more greenhouse emissions per year than transportation. This is where FuelPositive’s technology is expected to be extremely beneficial.

Management Team

Ian Clifford is Director, CEO and Founder of FuelPositive Corp. He has over 25 years of experience in the fields of technology and marketing and has successfully led the company to global brand recognition through its unique energy solutions. Since 2006, Mr. Clifford has raised over $50 million in equity financing for FuelPositive. He also co-founded digIT Interactive, a full-service internet marketing company serving Fortune 500 clients, which he sold at the peak of the market in 2000.

Greg Gooch serves as a Director and President of FuelPositive. His multifaceted career in the electronics and finance industries has positioned him as a key advisor and funding partner to start-ups and new technology companies for over 40 years. Mr. Gooch has been involved with FuelPositive since its early days and has remained a significant supporter and consultant to the company over the years. He has a bachelor’s from McGill University and an MBA from the University of Western Ontario.

Dr. Ibrahim Dincer is a scientific advisor to FuelPositive and is recognized as a pioneer and international leader in the area of sustainable energy technologies. Along with his team, Dr. Dincer invented the modular carbon-free ammonia (NH3) production technology that FuelPositive is commercializing. His area of specialty covers various topics including ammonia, hydrogen energy and fuel cells; renewable energy systems; energy storage systems and applications; carbon capturing technologies, and integrated and hybrid energy systems He is currently managing an exemplary team of researchers in this commercialization project.

Marek Warunkiewicz is the company’s Communications & Branding Specialist. He brings more than 40 years of entrepreneurial expertise to the FuelPositive team, having held marketing, branding, advertising, project management and graphic design positions with various companies. Mr. Warunkiewicz has successfully created business-to-business marketing and advertising campaigns for a diverse group of clients ranging from high-tech to agriculture. He co-founded digIT Interactive and ZENN Motor Company alongside Ian Clifford.

Luna Clifford is the Director of Communications for FuelPositive. She has over 10 years of experience as a business owner and advisor, helping build and operate several successful start-up enterprises while managing complex stakeholder relationships. Ms. Clifford excels in strategic planning and team building, and she has completed extensive studies in the fields of communications and health care.

FuelPositive Corp. (NHHHF), closed Friday's trading session at $0.1001, up 2.6667%, on 280,665 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.0789/$0.17.

Recent News

Advanced Container Technologies Inc. (OTC: ACTX)

The QualityStocks Daily Newsletter would like to spotlight Advanced Container Technologies Inc. (OTC: ACTX).

Last week, a group of senators re-introduced a measure to promote studies on the use of marijuana by veterans. It is expected that an identical bill will beintroduced in the House in the near-term. A congressional sourcehas revealed that the measure’s introduction in the House maximizesthe likelihood of its passage through both chambers. The bipartisanmeasure in question, the VA Medicinal Cannabis Research Act, directs that the U.S. Veterans Affairs’ department look into themedical potential of cannabis for military veterans, in particularthose who suffer from chronic pain and post-traumatic stressdisorder. The measure was sponsored by chair Jon Tester of theSenate Veterans’ Affairs Committee and Senator Dan Sullivan. Thisresolution was carried in previous sessions by Representative LouCorrea. As more states revise their drug laws, a larger market willpotentially open not just for “plant-touching” companies but alsoancillary companies that focus on addressing the needs of thecannabis companies, such as Advanced Container Technologies Inc. (OTC: ACTX).

Advanced Container Technologies Inc. (OTC: ACTX) is in the business of selling and distributing self-contained, automated, indoor “micro-farms” called Grow Pods, along with related equipment and supplies. Additionally, the company designs and sells patented proprietary medical-grade plastic containers, known as the Medtainer®, that store and grind pharmaceuticals, herbs, teas and other solids or liquids.

ACTX is the leading distributor of Grow Pods. With a controlled environment, food and herbs can be grown without pesticides, harmful chemicals or risk of pathogen contamination, and with low energy consumption. Restaurants, grocery stores, non-profits, MSOs and entrepreneurs can use Grow Pods to ensure a fresh supply of ultra-clean produce year-round.

The company entered the Grow Pod business in October 2020 with its acquisition of all shares of Advanced Container Technologies Inc., a California corporation. As of February 28, 2022, ACTX is exploring the acquisition of the assets and the assumption of some or all of the liabilities of GP Solutions Inc., the developer and manufacturer of Grow Pods, for which ACTX is currently the sole U.S. distributor.

Because Grow Pods can be located almost anywhere, produce can be grown closer to the point of consumption and harvested at its peak, providing nutritious fruits and vegetables where needed. Indoor micro-farms, utilizing a practice known as vertical farming, have attracted the attention of governments and universities, which are now promoting vertical farming as a way to combat food insecurity and inequities.

The United States Department of Agriculture (USDA) has stated that vertical farming “is no longer a futuristic concept.” The department is enthusiastic about vertical farming, particularly those utilizing repurposed shipping containers, such as Grow Pods. Arizona State University reports that vertical farming reduces water use by 90 percent compared to conventional farming but produces 10 times the crop yield.


Grow Pods

One of the company’s main business units is focused on selling advanced, self-contained hydroponic containers called Grow Pods. These unique and innovative automated systems are essentially micro-farms that can be placed virtually anywhere and, with their controlled and specially filtered environment, allow cultivation of a wide variety of crops, 365 days a year. The Grow Pod controlled environment offers major advantages for the production of high-value crops. The ability to grow year-round and the ability to cultivate in a smaller footprint using less water and power are some of the primary advantages of the system. Grow Pods offer constant temperature, humidity and airflow control, as well as automated watering and lighting schedules for optimal growth and minimal labor requirements, regardless of crop.


ACTX meets the needs of the pharmaceutical and medical markets, including the cannabis and hemp industries, with patented packaging systems. The company designs, customizes, brands and sells proprietary medical grade plastic containers that can store pharmaceuticals, herbs, teas and other solids or liquids, with a special built-in feature that can grind solids and shred herbs. The company’s flagship container product is the patented Medtainer®, a child resistant, medical-grade herb container and grinder that is water-tight, air-tight and smell proof. Packaging in the cannabis industry is critical, with numerous stringent regulations about how cannabis products must be packaged and labeled. ACTX also offers custom-branded, compliant vacuum seal bags and other retail container solutions.

Equipment and Supplies

ACTX markets and sells two principal products: Grow Pods, which are specially modified insulated shipping containers manufactured by GP Solutions Inc., in which plants, herbs and spices may be grown hydroponically in a controlled environment, and Medtainers®, which may be used to store pharmaceuticals, herbs, teas and other solids or liquids and can grind solids and shred herbs. The company also markets and sells various products related to Grow Pods and the Medtainer®, as well as providing private labeling and branding services for purchasers of Medtainers® and certain related products.

GP Solutions manufactures and sells other products, such as humidity controllers and LED lighting systems for vertical farming. The company’s specially designed lighting panels are programmed to emit the exact wavelength of light that each crop requires. The system has a daybreak-to-nightfall feature that gives plants the proper chromatic signals to grow rapidly and fruitfully. High efficiency LED light strips supply the crops with a red and blue light spectrum required for photosynthesis in the spectrum that plants need most.

Market Overview

The global vertical farming market is expected to reach $33.02 billion by 2030, according to a new report by Grand View Research. The market is forecast to expand at a CAGR of 25.5 percent from 2022 to 2030, according to Grand View. Escalating production of biopharmaceutical products, including cannabis, is anticipated to drive the market. The building-based segment of the market is expected to register a significant CAGR of 27.8 percent over the projected period. In addition, the climate control segment is expected to see high growth.

The global cannabis packaging market is expected to reach $14.34 billion by 2028, according to analysis by Reports and Data. The analysis forecasts 1,700 percent growth in cannabis users by the end of 2026, with packaging likely observing a whopping 26.42 percent growth in the forecast period. There are significant barriers to entry in the cannabis packaging market, giving an advantage to companies already established in the sector. These barriers include developing a thorough knowledge of the myriad regulations that govern cannabis packaging (which differ in each state), and child-resistance requirements.

Management Team

Douglas P. Heldoorn is the Founder and Chairman of Advanced Container Technologies Inc. He also holds the positions of President, CEO and COO at the company. Mr. Heldoorn has served on the Board of Directors since its inception in 2013. He has also previously held the position of Executive General Manager at Nissan Motor Corp.

Jeffory A. Carlson is CFO and Treasurer of ACTX. Mr. Carlson has also served as the company’s Corporate Controller since 2014.

Advanced Container Technologies Inc. (OTC: ACTX), closed Friday's trading session at $0.3805, even for the day. The average volume for the last 3 months is and the stock's 52-week low/high is $0.2005/$1.25.

Recent News

Delic Holdings Corp. (CSE: DELC) (OTCQB: DELCF)

The QualityStocks Daily Newsletter would like to spotlight Delic Holdings Corp. (CSE: DELC) (OTCQB: DELCF).

Psychedelics have been subject to an increasing amount of research in recent years in the wake of widespread drug reform. Althoughmost psychedelic research is still in its infancy, current studieshave revealed that hallucinogenic drugs are capable of inducing profound and long-term insights in users with minimal doses. This makes psychedelics a viabletreatment for a variety of mental health disorders, with studiesshowing that these substances are useful in the treatment and management of symptoms of conditions such as post-traumatic stress disorder,anxiety and treatment-resistant depression. Researchers haveposited that these benefits are derived from the fact thatpsychedelics can help change how users see themselves and the world around them. This, in turn, makes it easier for themto break through maladaptive thought patterns and develop healthierones instead. Many entities, such as Delic Holdings Corp. (CSE: DELC) (OTCQB: DELCF), are focusing on a number of hallucinogenic substances, and a lotmore information is likely to emerge regarding the numerousmedicinal uses that these compounds can have.

Delic Holdings Corp. (CSE: DELC) (OTCQB: DELCF) is the leading psychedelic wellness platform, committed to bringing science-backed benefits to all and reframing the psychedelic conversation. The company owns and operates an umbrella of related businesses, including trusted media and e-commerce platforms like Reality Sandwich and Delic Radio; Delic Labs, the only licensed entity by Health Canada to exclusively focus on research and development of psilocybin vaporization technology; Meet Delic, the premiere psychedelic wellness event; and Ketamine Infusion Centers, one of the largest ketamine clinics in the country.

Delic is backed by a team of industry and cannabis veterans and a diverse network, whose mission is to provide education, research, high-quality products, and treatment options to the masses. Its founders helped build the multi-billion-dollar cannabis industry and aim to do the same in psychedelics as it follows a similar path toward legalization. In its quest to advance the new psychedelic renaissance upon us, Delic has become the pioneer in its field, creating an ecosystem of opportunities by investing in cutting-edge ideas.

The Vancouver-based company was formed in 2019 to address the growing interest in psychedelic wellness backed by science. Delic was the ‎first psychedelic umbrella platform. It is currently a trusted source for those interested in ‎psychedelic culture, education, treatments, and more.

While other emerging companies focus on patent medicine and big pharma for substances limited by government regulation, Delic is blazing a unique trail. It identifies ancillary and fully legal opportunities like IP, new media, live events, ketamine clinics (with the ability to offer additional psychedelic treatments once legalized, and large-scale production and brings them under its big tent of resources and reach.

The Big Problems Delic Is Addressing

  • Fifty percent of Americans will meet the criteria for a mental health condition sometime in their lifetime. The FDA has approved psilocybin therapy as a breakthrough therapy for depression.
  • Every 40 seconds, someone in the world commits suicide. Ketamine has been shown to decrease thoughts of suicide significantly. In 2019, the FDA approved esketamine as a fast-acting antidepressant.
  • Traditional palliative care methods do not eradicate end-of-life (EOL) anxiety. LSD and psilocybin have been shown to reduce EOL anxiety for terminally ill patients. Eighty percent of terminally ill patients with psilocybin sessions experienced significant reductions in depression and anxiety.
  • Approximately 50 million people in the U.S. are addicted to some tobacco product. Research shows that psilocybin is helping people quit smoking.

The Delic Ecosystem

The Delic Ecosystem covers three main areas: media, health, and science. The media focus is educating and motivating the masses through a variety of digital platforms, like Delic’s Reality Sandwich digital magazine, a free public education platform providing psychedelic guides, news and ‎culture (1.4+ million page views in 2020 and 54k social media followers across all platforms); Meet Delic, the first-ever psychedelic wellness summit and the premier psychedelic wellness event based in Las Vegas (over 2,000 live attendees and 5,000+ email subscribers); and Delic Radio (over 43 episodes and 100k total streams). Delic has also been featured in numerous media outlets like Forbes, NBC News, The Joe Rogan Experience, Daily Beast, High Times, and The Dr. Drew Podcast.

The focus of Delic’s health operations is the most accessible psychedelic treatments that can help billions of people live happier lives. Delic does this through one of the largest ketamine clinic chains in the country, Ketamine Infusion Centers (KICs), a limited liability corporation formed under the laws of Arizona that runs three ketamine clinics located in Bakersfield, California, and Phoenix, Arizona. Its management team has over 15 years of experience in the clinic and medical space, scaling and operating over 20 clinics, with a plan to open 10 more clinics in the next 18 months. Together, these clinics have overseen 4,000+ treatments delivered to date.

The focus of Delic’s science operations is developing IP and advanced extraction and testing facilities that are the backbone of the legal market. Delic carries this out through Delic Labs, a licensed cannabis and psilocybin research laboratory based in Vancouver. It’s the only entity licensed by Health Canada to exclusively focus on research and development of psilocybin vaporization technology.

Founded by award-winning chemists, Delic Labs focuses on extraction optimization, analytical testing, and chemical process development to advance the cannabis and psilocybin industries. Health Canada gave it a Section 56 Exemption to work with psilocybin compounds, allowing the company to possess and research these products for development and quality control before they hit the market.

Latest Acquisition – Homestead Book Company

On March 4, 2021, Delic announced its acquisition of Seattle-based Homestead Book Company. Homestead is a legacy counterculture distributor of psychedelic media. It’s also the creator of one of the first self-contained psilocybin mushroom grow kits.

The acquisition of Homestead is an exciting one, as it shows how Delic is increasing accessibility to this nascent industry within regulated jurisdictions. Homestead has sold tens of thousands of mushroom kits globally and was one of the earliest distributors for High Times and many other counterculture publications.

The Homestead acquisition allows Delic to increase its product offerings on its website, Reality Sandwich, which recently hit a record for average monthly traffic of over 200,000 unique visitors and over 2.6 million active readers in 2020.

Market Outlook

The psychedelic renaissance is here. Just in time to help address the global mental health crises, plant medicines have the potential to help billions of people live happier lives. Thanks to university-led and FDA-approved studies, North America is leading the way in advancing an industry as psychedelics are becoming accepted globally for therapeutic, medical, and recreational use. Here are some statistics:

  • 32 million people in the U.S. have used psychedelics at least once
  • 17% of all American adults between 21 and 64 have used psychedelics at least once
  • $500 billion is spent in the U.S. every year on prescription drugs
  • $238 billion is spent in the U.S. every year on mental health treatments and ancillary services
  • The anxiety disorder and depression treatment market is estimated at $16 billion
  • $187.8 billion was spent in 2013 on mental health and substance abuse disorders

Management Team

Delic Co-Founder and CCO Jackee Stang was an executive at High Times, a leading counterculture publication that became the voice for the cannabis industry. The monthly magazine had a circulation of over 500,000 copies per issue. Its website attracted 500,000 to five million users each month by 2014.

Likewise, company Co-Founder and CEO Matt Stang was a previous owner and operator of High Times, a position from which he played an instrumental in legalizing cannabis in multiple states and launched the Cannabis Cup in America. After interacting with the cannabis community for two decades, he helped found Delic in 2019 as one of the first psychedelic corporations. He shapes the company’s vision and path using his expertise in branding, marketing, business development, and product viability.

Delic’s VP of Business Development, John Coleman, Ph.D., is a former president of Anandia Labs, a biotech company focused on genetics and analytics. Having experience in both science and business, Dr. Coleman is well-equipped to lead Delic’s business development efforts as it strives to enter new vertical markets.

Zak Garcia is the company’s Chief Marketing Officer. He was the former CMO of Bulletproof Inc., maker of the well-known Bulletproof Coffee brand. Mr. Garcia is a marketing and leadership strategist who helped grow Bulletproof Coffee to over $250 million in revenue.

Delic Holdings Corp. (DELCF), closed Friday's trading session at $0.03795, even for the day, on 54 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.022/$0.10023.

Recent News

REZYFi, Inc.

The QualityStocks Daily Newsletter would like to spotlight REZYFi, Inc.

Senators in Nebraska recently held a meeting to discuss a newly filed legislation that would legalize medical cannabis in the state. The lawmakersspent the hearing listening to testimonies from experts andadvocates on the therapeutic benefits of the cannabis plant. Themembers of the Judiciary Committee discussed a medical cannabis bill that was filed by Senator Anna Wishart nearly a month ago, before meeting later in the day to discuss separate measures thatwould legalize recreational cannabis in the state. Wishart has beenat the forefront of cannabis reform in Nebraska for several yearsnow, pursuing this reform through both activist-led ballot campaigns and legislative avenues. Her medical cannabis bill would allowpatients suffering from certain medical conditions to use cannabisfor medical purposes with a doctor’s recommendation. Wishart hasstated that her measure is one of the most conservative medicalmarijuana bills in the country and that it would allow patients inNebraska to access the medical care they deserve. She noted thatgrowing evidence had proven marijuana’s ability to alleviateconditions such as seizures and chronic pain. Furthermore, sheadded that medical cannabis would help address the need for opioiduse as it has proven to be an effective pain killer, without theside effects typically associated with opioid use. If the measuresgain eventual approval, companies that wish to participate in theindustry could find themselves needing funding from the likes of REZYFi Inc. or other entities that have created a niche around meeting thefinancing needs of marijuana companies in the absence of access tomainstream banks.

REZYFi, Inc. is a cannabis mortgage bank servicing the needs of both traditional and non-traditional consumers and businesses. Its target markets include licensed and permitted cannabis companies, owners of real estate who lease to cannabis companies, and companies and individual homeowners seeking a variety of real estate-related first and additional mortgage-based financing and project-specific financings, such as solar installations and real estate development projects.

Headquartered in Miami, Florida, REZYFi operates through two wholly owned subsidiaries – REZYFi Lending, which primarily addresses emerging real estate-related financing opportunities, and ResMac Inc., the company’s traditional mortgage origination, correspondent and servicing operation. REZYFi is currently licensed in 34 U.S. states, with plans to expand to all remaining states later this year.

REZYFi is positioned as one of first cannabis mortgage bankers in the U.S., while most traditional lenders are still reticent to serve the state-licensed cannabis industry.


REZYFi Lending

REZYFi Lending leverages a wide network to offer options such as 15- and 30-year fixed-rate loans, FHA loans, VA loans, reverse mortgages, jumbo loans and adjustable-rate mortgages.

Looking ahead, the company expects increased funding in marketing and loan agents to drive significant origination growth over the next two years, further supported by the planned launch of a high-margin cannabis division later this year.

ResMac Inc.

ResMac has been in operation for 13 years, having closed more than 20,000 loans for more than 15,000 clients. The company expects to accumulate $285 million in retail origination in 2023, alongside $250 million in wholesale origination for the same period. ResMac is further targeting $600 million in origination through its mortgage correspondent operations for 2023.

Through its ResMac subsidiary, REZYFi operates as a direct lender and originator of residential mortgages, with active mortgage correspondent and mortgage servicing operations. Through its correspondent segment, ResMac primarily purchases and aggregates residential mortgages from trusted third-party originators.

The company intends to harvest the database of customers within its mortgage servicing operations as an essential source of additional growth, especially relative to the new alternative residential loan programs being offered.

Corporate Strengths

  • Experience – REZYFi is led by a seasoned management team with significant expertise spanning a wide range of real estate and financing subsectors. The team also has extensive experience in the cannabis and hemp marketplace, which the company intends to leverage as it navigates the changing landscape of the cannabis industry while sourcing the best opportunities in the sector.
  • Network of Independent Brokers – Over the past five years, REZYFi has developed an extensive network of independent mortgage-related brokers and licensed loan officers. The company is currently training the network members on its new service offerings, with many already launching sales efforts. REZYFi believes this network will be a vital asset moving forward as other firms in the sector terminate relationships in the face of slowing mortgage business in a rising interest rate environment.
  • Proprietary Technology – REZYFi has invested heavily in designing, building and implementing proprietary automated/machine learning technology to shorten loan processing timeframes and increase efficiencies, allowing it to operate its legacy business at staffing levels meaningfully below those of its competitors.

Market Overview

REZYFi’s diversified approach to the real estate lending sector positions it to capitalize on growth in multiple verticals in the years to come.

In the first quarter of 2022, lenders issued 2.71 million residential loans, with the average balance for a first mortgage climbing to a record high of $298,324 in 2021, according to the Mortgage Bankers Association. This trend is expected to continue, with Freddie Mac forecasting a 10.4 percent increase in home prices in 2022 and a 5.0 percent bump in 2023. Growth prospects in the cannabis industry paint a similar picture.

The National Association of Realtors® issued a report in April 2021 examining the correlation between cannabis legalization and real estate demand. In states where prescription and recreational cannabis use is legal, more than a third of surveyed agents reported an increase in demand for warehouses. Likewise, 23 percent of those surveyed reported an increase in demand for storefronts, and 28 percent observed increased demand for land. As other states look to join the 19 that have embraced full cannabis legalization, this rising demand could create an opportunity for REZYFi’s cannabis-focused initiatives.

In total, an analysis by market research firm Business Research Insights projects the global loan servicing market to reach a value of nearly $1.5 billion by 2028, up from $680.8 million in 2021. Those figures represent a CAGR of 11.0 percent during the forecast period of 2022-2028.

Management Team

John Vu, Esq., is CEO of REZYFi, Inc. He has more than two decades of experience in the mortgage and commercial banking industry. He has filled many senior and executive management positions in high-producing mortgage banks, including C-level assignments. He has also served as general counsel for a nationally associated commercial bank. Mr. Vu brings considerable cannabis industry expertise to REZYFi. He has served as a corporate attorney to multiple cannabis cultivators, manufacturers and retailers.

Ji Ji Zhang, Esq., is CFO of REZYFi, Inc. He is a multifaceted entrepreneur who owns a law firm, a portfolio of hotels and a high-producing mortgage bank. Mr. Zhang is also an investor in the development of a cannabis business park. He brings more than five years of experience in mortgage banking to REZYFi, having developed Freddie Mac and HUD licenses and amassed a managed portfolio valued at over $300 million.

Kevin Heckemeyer is President of REZYFi, Inc. He has more than 25 years of experience in mortgage banking. He has built and sold several high producing mortgage businesses. In his current roles with ResMac, he is responsible for production and operations.

Spencer Dang is Chief Credit Officer of REZYFi, Inc. He has more than a decade of experience in mortgage operations. He is a direct endorsement underwriter for HUD and has specialized in non-QM underwriting. Under his watch as an underwriter, he has never had a single repurchase.

Recent News


McEwen Mining Inc. (NYSE: MUX) (TSX: MUX)

The QualityStocks Daily Newsletter would like to spotlight McEwen Mining Inc. (NYSE: MUX) (TSX: MUX).

Copper demand is rising worldwide, attributed to the renewableenergy market and, recently, the re-emergence of China after itslift of pandemic restrictions

McEwen Copper’s Los Azules project is positioned to help offsetsome deficit that is currently being experienced due to lossesrecorded by Peru and Chile mines coupled with high demand

The 2017 Preliminary Economic Assessment (“PEA”) estimated a36-year mine life for the Los Azules Copper Project – and onlycovered 55% of the known copper resources to be mined

Additional drill holes have shown strong copper mineralizationextending below the initial PEA bottom, providing an additionalbasis for Los Azules to become an even larger and longer-lastingmine

The renewable energy market is rising, expected to grow at a CAGRof 8.4% and reach a value of nearly $2 trillion by 2030, from$881.7 billion in 2020 ( A key component to achieving the growth of renewable energy iscopper, a sector currently facing a supply deficit, which isexpected by some analysts to last until 2030 due to rising demandrelated to renewable energy transition, as well as the ongoingpolitical unrest in Chile and Peru. Together these two countriesproduce 37% of the world’s annual production of copper. Peru,which accounts for 10% of the global copper supply, has alreadyreported Glencore's suspension of its Antapaccay copper mine afterprotestors looted and set fire to the location. Additionally,Chile, which accounts for 27% of the global supply, recorded a 7%year-on-year decline in November 2022. Goldman Sachs predicted thatChile's copper production will continue to decline ( Mining (NYSE: MUX) (TSX: MUX) is an asset-rich diversified gold and silver producer in theAmericas with large exposure to copper through its 68%-ownedsubsidiary McEwen Copper. The company recently reported rich coppervalues over attractive widths, resulting from infill drilling atits Los Azules project. “Located in San Juan, Argentina, Los Azulesis a large porphyry copper-gold-silver deposit expressing greatpotential, with ultimate depth and lateral extents yet to be fullydetermined… McEwen Copper resumed its drilling program in October2022. It is designed to increase drill hole density and upgrade thecopper resource classification to better understand the payback pitdesign. Also, the program will provide metallurgical, hydrologicaland geotechnical data to facilitate mine design and to determinehow much larger the deposit could be,” a recent article reads.“Most mined copper is currently used in infrastructure and newcritical demand emerging for use in electrification oftransportation and the global energy transformation. McEwen Copperis expected to be a game changer, potentially becoming the world’snext copper unicorn, and thus turbocharging McEwen Mining’s sharevalue.” To view the full article, visit

McEwen Mining Inc. (NYSE: MUX) (TSX: MUX) is an asset rich diversified gold and silver producer in the Americas and has a large exposure to copper through its subsidiary, McEwen Copper, owner of the Los Azules copper deposit in Argentina, believed to be the 9th largest undeveloped copper resource in the world.

Led by a management team with a track record of success, MUX owns and operates mines in some of the most prolific gold producing regions in the Americas. In recent months, the company has undertaken strong actions to lower production costs and increase production across its portfolio of gold assets, driving some costs below the industry average. Gold and copper prices are forecast to enter a major uptrend over the next couple years. McEwen Mining is laying the groundwork to capitalize on this opportunity now.

Seldom is management so aligned with investors’ interests with a commitment to the company’s success. CEO Rob McEwen maintains a 17% ownership stake in McEwen Mining and a 15% ownership in McEwen Copper with a combined cost base of roughly $220 million. McEwen founded Goldcorp, where he took the company from a market capitalization of $50 million to over $8 billion, and that same vision led MUX to create McEwen Copper.

For McEwen Mining shareholders, the company’s 68% stake in McEwen Copper is expected to be a gamechanger, turbocharging MUX by creating the world’s next copper unicorn.

McEwen Copper

Most mined copper is currently used in infrastructure, with new critical demand emerging for use in the electrification of transportation and the global energy transformation. The price of copper rose from a low of about $2 per pound two years ago to over $4 per pound today, and strong demand is expected to continue to soar. A study by S&P Global, titled The Future of Copper: Will the Looming Supply Gap Short-circuit the Energy Transition?, projects global copper demand to nearly double over the next decade, from 25 million metric tons today to about 50 million metric tons by 2035. Based on current trends, S&P Global projects annual supply shortfalls to reach nearly 10 million metric tons in 2035.

McEwen Mining is a 68% shareholder in McEwen Copper, holder of a 100% interest in the Los Azules copper project in San Juan, Argentina, which was ranked the 9th largest undeveloped copper deposit in the world by Mining Intelligence (2022). Its current copper resources are estimated at 10.2 billion pounds at a grade of 0.48% Cu (Indicated category) and an additional 19.3 billion pounds at a grade of 0.33% Cu (Inferred category). McEwen Copper also owns a copper exploration project in Nevada, called Elder Creek.

In a 2017 Preliminary Economic Assessment (PEA), Los Azules was estimated to have a 36-year life, but indications are that the project could ultimately become an even larger mine, with a longer life, since in the assessment, only 55% of the known copper resources are to be mined. Numerous drill holes have shown strong copper mineralization extending below the PEA pit bottom. Its average annual production for its first 13 years was pegged at 415 million pounds of copper in the 2017 PEA – enough copper to supply 2.2 million electric vehicles per year.

In August 2022, McEwen Copper closed its non-brokered, private placement offering of $82 million, after securing a $25 million investment from mining giant Rio Tinto’s technology arm, Nuton LLC. This gives McEwen Copper an imputed value of $258 million, which would give McEwen Mining’s 68% interest a value of approximately $3.70/share. Additional value can be attributed to McEwen Mining’s 1.25% net smelter royalty on both the Los Azules and the Elder Creek projects.

“We completed an $82 million financing for McEwen Copper in a very tough equity market. Rio Tinto, the second largest mining company in the world, through its subsidiary Nuton, now owns 9.7% of McEwen Copper, a result of its investment of $25 million,” Rob McEwen stated in a news release. “Also, Nuton is testing the Los Azules copper mineralization to see if it can accelerate and increase copper recoveries. Another of Rio Tinto’s subsidiaries, Kennecott Exploration, signed an option to earn a 60% interest in McEwen Copper’s other copper project, Elder Creek, by spending $18 million on exploration.”

The Elder Creek project is prospective for porphyry copper and gold mineralization and is well situated in a district hosting several large copper and gold mines, including Marigold, Lone Tree and Phoenix. Kennecott Exploration will be the operator of the exploration program. McEwen Mining holds a 1.25% net smelter return (NSR) royalty on the Elder Creek property.

Following the capital raise, McEwen Copper is well-funded to advance its Los Azules Project. Publication of an updated PEA on the Los Azules copper project is planned for Q1 2023. In Q2, an IPO is planned, along with MUX completing a secondary offering, assuming no further private placements in the interim. MUX is strategically reducing its interest to increase its treasury, in order to reduce debt and fund the further development of its gold and silver mines.

McEwen Copper currently has an implied market cap of over $258 million, based on its most recently completed financing. However, when its Los Azules copper project is compared with other recent transactions and market valuations of copper projects in the same region, it appears very undervalued.

MUX’s management believes its ownership stake in McEwen Copper is not currently reflected in the share price of the company. In fact, it is management’s belief that the combined value of its 68% interest in McEwen Copper, plus its gold mines and portfolio of mineral royalties, represents a share value ranging from a low of $8 to a high of $30 per share. Rob McEwen provides a full breakdown of this valuation estimate in a news release detailing the company’s Q3 2022 results.

Gold & Silver Projects

The Fox Complex

McEwen Mining owns a 100% stake in the Fox Complex in the heart of a prolific gold district in Timmins, Canada.

“When MUX bought the Fox Complex, in late 2017, it was a distressed asset with a history of high operating cost/oz. While it has taken longer than I expected, the cost to produce an ounce of gold is significantly lower,” CEO Rob McEwen stated in a news release. “I am pleased to say that in Q3 our cash cost/oz at Fox fell to $774, our lowest since mid-2018. This is well below the industry average. With our mine operating much more efficiently, our next important area to improve at Fox is the process plant (mill). Specifically, we need to increase the throughput because our mine is now producing more ore than our mill can process. As a result, we have a large surface stockpile of ore equivalent to more than two months of production.”

This ore stockpile contains approximately 10,000 ounces of gold representing a potential source of $12 million in free cash flow.

Located in one of the most prolific gold production areas in the world, along the Destor-Porcupine Fault Zone within the Abitibi Greenstone Belt, the Fox Complex includes the Black Fox mine and Froome mine which together have, so far, produced in excess of 1,000,000 ounces of gold. Also, it includes the Grey Fox and Stock deposits that have an estimated additional 1,600,000 ounces in reserves and resources. The 2.7-billion-year-old Abitibi Greenstone Belt, formed by ancient volcanic activity, has proved to be one of the world’s richest and most abundant gold regions, boasting total gold content of over 300 million ounces.

Full year 2023 guidance for The Fox Complex puts production estimates at 45,000 GEOs, 28% of MUX’s total production.

The Gold Bar Mine

McEwen Mining owns a 100% stake in the Gold Bar mine located in an area well known for gold production, the southern Roberts Mountains of the Battle Mountain-Eureka-Cortez gold trend in Eureka County, Central Nevada. The Gold Bar mine is on the same geological structure some 25 miles south of Nevada Gold Mines, a joint venture of Barrick and Newmont. This Cortez-Goldrush complex contains estimated reserves and resources of greater than 50 million gold ounces. Its annual gold production is 1,000,000 ounces.

Gold Bar had been previously mined, between 1991 and 1994, producing 134,000 gold ounces. MUX built a new facility in 2019. The open pit mine was expected to be a large contributor to MUX’s revenue and gold production, however operating challenges arose that reduced gold production and drove cost/oz unacceptably high. Mining activities have shifted recently to a nearby, satellite deposit called Gold Bar South (GBS). Going forward the expectations are higher gold production and lower operating cost/oz as a result of mining a higher ore grade (concentration of gold per ton) and having to move half the amount of material to capture an ounce of gold.

“At Gold Bar, we are looking forward to starting to mine our GBS deposit this quarter,” McEwen said in a November 2022 release. “We are expecting to have a much lower cost/oz than our YTD cost because we will be mining higher grade ore at GBS, with half the strip ratio and no problematic carbonaceous material.”

The Gold Bar Mine will account for approximately 28% of McEwen Mining’s 2023 total attributable production, with guidance pegged at 45,000 GEOs. Most of Gold Bar production in 2023 will be from GBS.

El Gallo/Fenix

Project Fenix is the proposed redevelopment plan for McEwen Mining’s El Gallo Complex in Mexico. There is a long history of mining in this region. MUX’s involvement began in 2013 operating it as an open pit, heap leach mine which produced 281,000 gold equivalent ounces at average cash cost of $655 per ounce. However, due to the transition to deeper sulfide mineralization that is not amenable to heap leaching, mining activities ceased in the second quarter of 2018. The redevelopment envisions constructing a mill at the existing mine site that will initially reprocess the existing heap leach material then transition to open pit mining and processing the sulphide mineralization. The company recently acquired a complete process plant on very advantageous terms that has considerably reduced the projected capital requirements for the project.

CEO Rob McEwen stated in a news release, “This acquisition has made Fenix more attractive to build and could provide a new long life mine for McEwen Mining.”

The initial development approach is to build a mill to reprocess the material on the heap leach pad and produce approximately 17,000 oz of gold annually for eight years. Construction of the Fenix project is expected to be completed by early 2024.

Mine San José

McEwen Mining is a 49% owner and non-operator of the San José gold and silver mine located in Santa Cruz province, Argentina. This high-grade underground mine has been operating since 2007 and currently has an expected life of six years with a reserve grade of 342 gpt silver and 5.7 gpt gold and a resource grade of 427 gpt silver and 7.0 g/t gold.

“The San José mine, where we have a 49% interest, put in a strong quarter and its exploration is continuing to extend its high-grade veins and discover new veins,” McEwen noted in a news release.

Production guidance for 2023 for MUX’s 49% is 70,000 GEOs, 44% of MUX’s total production. As a minority shareholder in the mine, MUX equity accounts for its investment in San Jose, and it receives 49% of the dividends from the mine’s free cash flow.

Market Outlook

Mining stocks took a beating in the wake of the COVID-19 pandemic. However, that could change, as many analysts are now forecasting a gold bull market in 2023.

“The operating challenges we faced in recent years have severely damaged our credibility with our shareholders and the market. As a result, few investors have taken a close look recently at our assets,” Rob McEwen said in a news release. “If they did, I believe some would see the potential value that I see today… I believe there is considerable potential value in MUX, and that is a big reason why I have a personal financial commitment of $220 million in MUX and McEwen Copper.”

Management Team

Robert R. McEwen is Chairman, CEO and Chief Owner of McEwen Mining. He has been associated with the gold industry all his career, with his first 18 years in the investment industry and, since 1990, as CEO of several gold mining companies. He founded Goldcorp and took that company from a $50 million market capitalization to more than $8 billion. He owns 17% of McEwen Mining and is in complete alignment with investors – the cost of his investment in MUX and McEwen Copper is $220 million and he takes an annual salary of only $1. He was awarded the Order of Canada and the Queen Elizabeth’s Diamond Jubilee Award, was inducted into the Mining Hall of Fame, was named an Ernst and Young Entrepreneur of the Year and has Honorary Doctor of Law degrees from York University and Western University.

William Shaver is interim COO and a Director of McEwen Mining. He has decades of management and executive experience in mine design, construction and operations. He was a founder of Dynatec Corporation, which became one of the leading contracting and mine operating groups in North America. In 2013, he was recognized as Ernst and Young Entrepreneur of the Year. Most recently, he served as COO of INV Metals. He is a Professional Engineer with a B.Sc. in Mining Engineering from Queens University.

Perry Ing is interim CFO at McEwen Mining. He has 25 years of experience in the Canadian mining industry. Over the past 15 years, he has held positions as CFO of Mountain Province Diamonds, Kirkland Lake Gold and McEwen Mining. Prior to that, he worked at Barrick Gold and Goldcorp and started his career in the mining practice at PwC. He has a Bachelor of Commerce from the University of Toronto and is a Chartered Professional Accountant in Canada and Certified Professional Accountant in the U.S.

Adrian Blanco S. is the company’s Director – America and Mexico Operations. He has extensive international experience in several industrial sectors and has held executive positions in Mexico, the United States, Peru and Argentina. He joined the McEwen Mining team in 2015 and has led a successful business transformation toward operational discipline, best business practices and financial profitability at subsidiaries Compañia Minera Pangea and McEwen Mining Nevada. He graduated from an Executive Management Program at IPADE and Harvard Business School.

Michael Meding is Vice President and General Manager of McEwen Copper. He has over 20 years of international experience, primarily with major mining companies such as Barrick Gold and Trafigura, including extensive experience with project development and operations in Argentina. While at Barrick Gold’s Veladero mine in Argentina, Mr. Meding played a key role in the turnaround, extension of the mine life and subsequent strategic partnering with Shandong Gold. He holds an MBA from Indiana University in Pennsylvania and an MBA from the Leipzig Graduate School of Management in Germany.

McEwen Mining Inc. (NYSE: MUX), closed Friday's trading session at $5.91, off by 1.8272%, on 299,568 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $2.81/$9.78.

Recent News

CNS Pharmaceuticals Inc. (NASDAQ: CNSP)

The QualityStocks Daily Newsletter would like to spotlight CNS Pharmaceuticals Inc. (NASDAQ: CNSP).

University of Waterloo researchers have created a tool thatleverages artificial intelligence (AI) to personalize breast cancertreatment. The development of machine learning and artificial intelligence technology in recent years has been a game changer, allowing professionals in various industries to streamlineprocesses and gain results that are more effective without havingto hire more workers. This technology can be especially beneficialin the medical industry, as it allows physicians to analyzeextremely large data sets and come up with better and more effective ways of treating patients.Given that breast cancer is one of the most common types of cancerin the United State. and across the world, researchers were boundto employ AI technology in efforts to improve breast cancertherapies. Researchers from the University of Waterloo used this technology to develop a tool that can allow cancerspecialists to determine whether breast cancer patients shouldreceive chemotherapy treatment before undergoing surgery to removeas much of the tumor as possible. With so many enterprises such as CNS Pharmaceuticals Inc. (NASDAQ: CNSP) devoting research resources to different kinds of cancer, a timeis coming when patients will stand a better chance of beating thedifferent malignancies afflicting them.

CNS Pharmaceuticals Inc. (NASDAQ: CNSP) is a clinical stage biotechnology company specializing in the development of novel treatments for primary and metastatic cancers of the brain and central nervous system.

The company was founded in 2017 and is headquartered in Houston, Texas.

Organ Targeted Therapeutics

The company’s lead drug candidate, Berubicin, is proposed for the treatment of glioblastoma multiforme (“GBM”), an aggressive and incurable form of brain cancer. Berubicin also has potential to treat other central nervous system malignancies. Based on limited clinical data, Berubicin appears to be the first anthracycline to cross the blood brain barrier in the adult brain, and it was the subject of a successful Phase 1 study which found the MDT and produced efficacy data as well.

CNS holds a worldwide exclusive license to the Berubicin chemical compound. The company has acquired all requisite data and know-how from Reata Pharmaceuticals Inc. related to a completed Phase I clinical trial of Berubicin in malignant brain tumors. In this trial, 44% of patients experienced a statistically significant improvement in clinical benefit. In 2017, CNS entered into a collaboration and asset purchase agreement with Reata.

CNS intends to explore the potential of Berubicin to treat other diseases, including pancreatic and ovarian cancers and lymphoma. The company is also examining plans to develop combination therapies that include Berubicin.

CNS estimates that more than $25 million in private capital and grants were invested in Berubicin prior to the company’s $9.8 million IPO in November 2019.

CNS intends to submit an IND for Berubicin during the fourth quarter of 2020 and expects to commence a Phase II clinical trial of Berubicin for the treatment of GBM in the U.S. in Q1 2021. A sub-licensee partner was awarded a $6 million EU/Polish National Center for Research and Development grant to undertake a Phase II trial of Berubicin in adults and a first-ever Phase I trial in pediatric GBM patients in Poland in 2021.

The company’s second drug candidate, WP1244, is a novel DNA binding agent licensed from the MD Anderson Cancer Center. In preclinical studies, WP1244 proved to be 500-times more potent than the chemotherapeutic agent, daunorubicin, in inhibiting tumor cell proliferation. The company has entered into a sponsored research agreement with the MD Anderson Cancer Center to further the development of WP1244.

CNS Pharmaceuticals recently engaged U.S.-based Pharmaceutics International Inc. and Italian BSP Pharmaceuticals SpA for the production of the Berubicin drug product. The company has implemented a dual-track manufacturing strategy to mitigate COVID-19-related risks, diversify its supply chain and provide for localized availability of Berubicin. CNS has already completed synthesis of Berubicin’s active pharmaceutical ingredient (API) and has shipped the API to both manufacturers in order to prepare an injectable form of Berubicin for clinical use.

Global Brain Tumor Therapeutics Market

The high recurrence rate of malignant brain tumors is due to reappearance of focal masses, indicating that a sub-population of tumor cells in these cancers may be insensitive to current therapies and may be responsible for reinitiating tumor growth. This necessitates the development of newer drugs in the market that demonstrate greater efficacy in treating such aggressive cancers.

A global increase in neurological disorders has placed increased attention on cancers of the brain over the past decade. Neurological disorders are becoming one of the most prevalent types of disorders, due to longer life expectancy, greater exposure to infection and an increasingly sedentary lifestyle. Because few treatments for primary and metastatic cancers of the brain exist, costs are high and have acted as a restraint for the brain tumor therapeutics market.

Despite progress in surgery, radiotherapy and chemotherapeutic strategies, effective treatments for brain cancer are limited by a lack of specific therapies for the brain and the difficulty in transporting therapeutic compounds across the blood brain barrier. Therefore, there is a significant need for novel and effective therapeutic drugs and strategies that prolong survival and improve quality of life for brain tumor patients.

Several companies are making significant investments into R&D, which is expected to bring more treatment options to the market in the near future. Industry reports consistently project continued growth in the market.

One report estimates that the global brain tumor therapeutics market will reach a valuation of $2.74 billion in 2023, with the market expected to register a CAGR of 11% during the forecast period from 2018 to 2023. Another report projects that the global brain tumor therapeutics market will reach $3.4 billion by 2025, up from $2.25 billion in 2019 (

Management Team

John M. Climaco is the CEO of CNS Pharmaceuticals. For 15 years, Climaco has served in leadership roles for a variety of health care companies. Recently, Climaco served as the Executive Vice President of Perma-Fix Medical S.A, where he managed the development of a novel method to produce Technitium-99. Climaco also served as President and CEO of Axial Biotech Inc., a DNA diagnostics company. In the process of taking Axial from inception to product development to commercialization, Climaco forged strategic partnerships with Medtronic, Johnson & Johnson and Smith & Nephew.

Christopher Downs, CPA, is the company’s Chief Financial Officer. Downs previously served as Interim Chief Financial Officer and Executive Vice President of InfuSystem Holdings Inc. (NYSE: INFU), a supplier of infusion services to oncologists in the United States. Downs holds a Bachelor of Science from the United States Military Academy at West Point, an MBA from Columbia Business School and a Master of Science in Accounting from the University of Houston-Clear Lake.

Dr. Donald Picker is the Chief Scientific Officer of CNS. Picker has over 35 years of drug development experience. Prior to joining CNS, Picker worked at Johnson Matthey, where he was responsible for the development of Carboplatin, one of the world’s leading cancer drugs, which was acquired by Bristol-Myers Squibb with annual sales of over $500 million. In addition, he oversaw the development of Satraplatin and Picoplatin, third-generation platinum drugs currently in late-stage clinical development.

Sandra L. Silberman, M.D., Ph.D., is the Chief Medical Officer of CNS Pharmaceuticals. Silberman is a hematologist/oncologist who earned her B.A., Sc.M. and Ph.D. from the Johns Hopkins University School of Arts and Sciences, School of Public Health and School of Medicine, respectively, and her M.D. from Cornell University Medical College. She then completed both a clinical fellowship in hematology/oncology and a research fellowship in tumor immunology at the Brigham & Women’s Hospital and the Dana Farber Cancer Institute in Boston, Massachusetts. Silberman has played key roles in the development of many drugs, including Gleevec(TM), for which she led the global clinical development at Novartis. Silberman advanced several original, proprietary compounds into Phases I through III during her work with leading biopharmaceutical companies, including Bristol-Myers Squibb, AstraZeneca, Imclone and Roche.

CNS Pharmaceuticals Inc. (NASDAQ: CNSP), closed Friday's trading session at $1.67, off by 4.023%, on 36,046 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $1.58/$16.50.

Recent News

Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF)

The QualityStocks Daily Newsletter would like to spotlight Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF).

China currently dominates the high-value market for rare earthelements (“REE”), but growing political tensions increasinglythreaten this key supply chain, limiting the potential distributionof REE for crucial high-tech applications, such as military assets,electric vehicles, wind power generation, as well as mobile phones,and many others

Ucore’s mission includes an ESG-centered model using RapidSXtechnology for the refining of REE from U.S. Allied sources,including Canada, as well as Louisiana and Alaska

The REE market was valued at $5.3 billion in 2021 and is expectedto continue growing quickly, at a CAGR of over 12%, resulting in avalue of approximately $9.6 billion by 2026

Recent events have brought to light serious tensions that currentlyexist between the U.S. and China – including the Chinese spyballoons recently shot down in U.S. airspace and China’s angertoward the U.S. for an increased military presence planned for thePhilippines. China has moved to claim dominance in the South ChinaSea, considering the waters as its own, in direct opposition tosurrounding nations, such as the Philippines, and internationallaw. These tensions threaten to disrupt current trade relations,including the distribution of vital rare earth elements (“REE”), onwhich China currently has a virtual monopoly.Ucore Rare Metals (TSX.V: UCU) (OTCQX: UURAF), a company focused on rare earth element (“REE”) resourcedevelopment and precious metal commercialization, recently providedan update on the commissioning process for its RapidSX(TM)Demonstration Plant for the separation of heavy and light REEs.“Ucore’s vision includes becoming a leading advanced technologycompany that provides the best-in-class metal separation productsand services to the mining and mineral extraction industry. Thecompany also plans to aid in developing the North American REEsupply chain controlled by the U.S. and its allies throughstrategic partnerships,” a recent article reads. “Innovation MetalsCorp., which was acquired by Ucore in 2020, developed theRapidSX(TM) technology – with early-stage assistance from theUnited States Department of Defense. This has resulted in theproduction of commercial-grade, separated REE at the pilot scale.Utilizing chemistry similar to traditional solvent-extraction(‘SX’) technology, RapidSX(TM) is not ‘new’ technology but rather asignificant improvement on well-established, well-understood andproven conventional separation technology preferred by leading REEproducers.” To view the full article, visit

Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) is engaged in Rare Earth Element (REE) resource development and in commercializing its critical metals separation technology, RapidSX™, for the mining and metals extraction industry. The company is guided by principles of environmental, social and corporate governance (ESG) with a focus on disrupting China’s current dominance of the U.S. REE supply chain.

Ucore’s vision is to become a leading advanced technology company providing best-in-class metal separation products and services to the mining and mineral extraction industry. It plans to aid in the development, through strategic partnerships, of a North American REE supply chain controlled by the U.S. and its allies.

The company intends to contribute to this initiative through the near-term development of a heavy and light rare-earth processing facility in Louisiana and subsequent development of Strategic Metals Complexes (SMCs) in Alaska and Canada, as well as through the longer-term development of its 100%-owned Heavy Rare Earth Element (HREE) mineral resource property at Bokan Mountain on Prince of Wales Island, Alaska.

Ucore is headquartered in Halifax, Nova Scotia.

Projects & Technology

RapidSX™ Demonstration Plant

The Kingston, Ontario, RapidSX™ Demonstration Plant commissioning process is underway. Once commissioned, the plant is designed to demonstrate the commercial capabilities of the RapidSX technology platform.

The RapidSX demo plant will show:

  • The techno-economic advantages of the RapidSX technology platform
  • The processing of tens of tons of heavy and light mixed rare earth element concentrates in a simulated production environment
  • The platform’s ability to operate for thousands of semi-continuous run-time hours
  • Production of high-purity NdPr, praseodymium, neodymium, terbium and dysprosium rare earth elements for early OEM product qualification trials

The demo plant is located within Ucore’s 5,000-square-foot RapidSX Commercialization and Demonstration Facility and is run by its laboratory partner, Kingston Process Metallurgy Inc. (“KPM”).

RapidSX™ Technology

Innovation Metals Corp., acquired by the company in 2020, developed the RapidSX separation technology platform with early-stage assistance from the United States Department of Defense, later resulting in the production of commercial-grade, separated rare earth elements at pilot scale.

RapidSX combines the time-proven chemistry of conventional solvent extraction (SX) with a new column-based platform that significantly reduces time to completion and plant footprint, as well as potentially lowering capital and operating costs. SX is the international REE industry’s standard commercial separation technology and is currently used by all REE producers worldwide for bulk commercial separation of both heavy and light REEs.

Utilizing similar chemistry to conventional SX, RapidSX is not a “new” technology, but it represents a significant improvement on the well-established, well-understood, proven conventional SX separation technology preferred by REE producers.

Strategic Metals Complex

Ucore, engineering partner Mech-Chem Associates Inc. and KPM are developing the full-scale engineering for the company’s first Strategic Metals Complex (SMC). The SMC is a planned REE separation and rare earth oxide production plant slated to commence construction in Louisiana in 2023. It is scheduled to initially process 2,000 tons of total rare earth oxides by the end of 2024, increasing to 5,000 tons in 2026.

Bokan-Dotson Ridge REE Deposit

Ucore has invested over C$35 million to establish and validate the Bokan-Dotson Ridge resource in preparation for mine design and permitting. Initial drilling is complete, and a Preliminary Economic Assessment has been issued. Next steps for the project include a feasibility study, detailed mine design and permit acquisition. The project can be “near shovel ready” for construction in less than 30 months after receipt of the next stage of development funding.

Market Opportunity

According to a report by Grand View Research, the global rare earth elements market was valued at $2.8 billion in 2018 and is forecast to reach a value of $5.6 billion by 2025, achieving a CAGR of 10.4% during the period. Market growth is driven by increasing demand for these elements in the manufacturing of magnets and catalysts for the automotive industry. Rising demand for electric vehicles to reduce CO2 emissions is expected to propel the use of permanent magnets in the production of EV batteries.

China is the major producer and consumer of REEs. To maintain self-sufficiency and to meet future demand, China has been raising the export tariffs on rare earth elements shipped to various countries, including the U.S., Japan, India, Brazil and the European Union. This led to the current supply-demand gap in these countries, as they rely on imports from China.

China reduced the exports of REEs by 72% in the second half of 2010 to preserve its reserves of these elements and continues to export REEs at reduced levels, thereby affecting industries such as automotive, oil and gas, and electronics, which require an ample amount of rare earth elements.

Management Team

Pat Ryan, P.Eng., is Chairman and CEO of Ucore Rare Metals. He began as a director with the company when he developed a heightened interest in critical metals. Before joining Ucore, he founded and led a multimillion-dollar automotive OEM design and lean manufacturing company. His understanding of complex supply chains across international markets has led to a prime positioning as the global auto industry transitions to vehicle electrification. He holds a Bachelor of Engineering degree from Dalhousie University.

Peter Manuel is Vice President and CFO of Ucore. Prior to joining the company, he practiced as a Chartered Accountant for more than 17 years, providing consulting services to companies in a range of industries, with a focus on the financial services and resource sectors. He spent 10 years in England and Ireland providing assurance, strategic planning, corporate finance and other consulting services to a portfolio of both public and private entities. He holds a Bachelor of Commerce Degree from Dalhousie University.

Michael Schrider, MEng, P.E., is Vice President and COO of Ucore. He is a multidisciplinary engineer who has been involved in manufacturing, engineering and managing complex structural and mechanical systems projects since 1989. He was the Founder, President and Chief Engineer of Schrider & Associates and Alton Bay Design, both engineering services firms. He holds a bachelor’s degree in naval architecture and marine engineering from the University of New Orleans and a master’s degree in mining, geological and geophysical engineering from the University of Arizona.

Mark MacDonald is Vice President of Investor Relations at Ucore. He has over 25 years of experience implementing award winning business development and marketing programs at regional and national levels. As Vice President of Sales, he was responsible for Mediapro Communication’s growth as AT&T Canada’s leading B2B sales partner. He subsequently became Atlantic Regional Vice President of AT&T Canada Corp. He holds a Bachelor of Commerce degree from Dalhousie University.

Ucore Rare Metals Inc. (UURAF), closed Friday's trading session at $0.92, off by 3.3004%, on 33,053 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.40/$1.05.

Recent News

Freight Technologies Inc. (NASDAQ: FRGT)

The QualityStocks Daily Newsletter would like to spotlight Freight Technologies Inc. (NASDAQ: FRGT).

Freight Technologies (“Fr8Tech”) is a North American transportationlogistics technology company streamlining and simplifying the oncecomplex process of over-the-road (“OTR”) shipping

Through its AI-powered Fr8app B2B marketplace, Fr8Tech connectsshippers with carriers, helping reduce waste and inefficiency, andpromoting security and visibility

The company’s system is handy at a time when trade among parties tothe USMCA is on an uptrend

The continuous growth of trade among Canada, Mexico, and the UnitedStates, depends on the efficiency of trade support structures, suchas the logistics-oriented technologies and services Fr8Tech isproviding

In the years since the North American Free Trade Agreement(“NAFTA”) took effect in 1994 until it was renegotiated, all threeparticipating countries’ economies benefited greatly. “Regionaltrade increased sharply over the treaty’s first two decades, fromroughly $290 billion in 1993 to more than $1.1 trillion in 2016.Cross-border investment also surged,” a 2020 article in the Councilon Foreign Relations reads ( Freight Technologies (NASDAQ: FRGT) (“Fr8Tech”), a North American transportation logistics technologycompany, the direct relationship between successful, efficienttrade and logistics services has always been clear. Through itsin-house technologies, which are powered by artificial intelligence(“AI”), Fr8Tech seeks to modernize operations for shippers andcarriers in Mexico, Canada, and the US by optimizing logistics,reducing transportation costs, and making fleets more efficient.

Freight Technologies Inc. (NASDAQ: FRGT) (“Fr8Tech”) is a technology company developing solutions to optimize and automate the supply chain process, providing a platform for B2B cross-border shipping in the NAFTA region. The company’s mission is to revolutionize cross-border shipping by providing carriers with increased growth opportunities and shippers with flexibility, visibility and simplicity for the once-complex process of international over-the-road shipping.

Freight Technologies, formerly known as Hudson Capital Inc., assumed its current name and ticker symbol on May 27, 2022. Its primary operating subsidiary and its marketplace are known as Fr8App, and it conducts operations throughout North America under the names of Fr8App and/or Freight App. The company is headquartered in Houston, Texas, with multiple locations across the U.S. and Mexico.

The Fr8Tech Solutions Suite

Fr8Tech leverages artificial intelligence to provide cloud-based platforms aimed at automating the over-the-road transportation process, effectively reducing human touch points and expediting load booking times. The company’s suite of solutions includes:

  • Fr8app – A B2B marketplace powered by AI and Machine Learning offering a real-time broker portal to connect shippers with qualified carriers
  • Fr8Radar – A tracking solution providing shippers and carriers real-time locational data via Fr8app’s mobile solution or through integration with third-party GPS alternatives
  • Fr8TMS – A transportation management system designed to help shippers manage their freight and all of the documents involved in shipping transactions, including invoices, customs documents, confirmation rates and proof of deliveries
  • Fr8FMS – A fleet management system allowing transportation companies to better manage their fleets, reduce operational costs and provide better service to their customers
  • Fr8Data – A data solution offering real-time dashboards and reports to shippers and carriers in an effort to increase visibility and control while supporting better business decisions
  • Fr8Fleet – A platform that provides private fleet management, enabling large corporate shippers to purchase dedicated capacity secured by Fr8app in exchange for a fixed fee

Commitment to the Environment

Through its core focus on technology, Fr8Tech seeks to reduce the carbon footprint of the logistics industry. Its solutions aim to minimize empty miles for transportation firms and reduce overall paper consumption.


Fr8University is an educational program offering classroom and on-the-job training for Fr8Tech team members. Through the program, employees learn in-depth business fundamentals and applications along the truckload freight industry value chain.

Led by corporate educator Mario Mena, Fr8University is designed as an investment in the company’s human capital, providing an opportunity to communicate Fr8Tech’s corporate culture while accelerating operational growth.

Market Outlook

Fr8Tech’s established foothold in Mexico is key to its current efforts to promote sustainable growth in the cross-border shipping industry. Ongoing disruption in U.S.-Chinese trade relations have strengthened Mexico’s status as the largest trading partner of the U.S., with cross-border annual freight spending estimated at $385 billion according to data from the U.S. Department of Transportation. Annual domestic shipping in Mexico is estimated at $34 billion, while annual domestic shipping in the U.S. is estimated to total $732 billion.

Despite the size of this industry, fragmentation and inefficiencies prevail in the space. Thousands of legacy brokers, tens of thousands of shippers and hundreds of thousands of carriers still rely on outdated systems to arrange transport, spending hours on the phone negotiating pricing, waiting days to find trucks and drivers, preparing and printing forms, and operating without tracking or visibility. Add in cross-border complexity relating to customs and additional paperwork, and you have an industry ripe for technological disruption.

Fr8Tech’s recent revenue growth trends have highlighted the company’s efforts to capitalize on this opportunity. In 2021, Fr8Tech achieved revenues of $21.5 million, marking a year-over-year increase of 134%. The company issued revenue guidance for fiscal 2022 of $40 million in a February 9, 2022, press release, which would account for a further 86% year-over-year increase.

Management Team

Javier Selgas is CEO and a Director of Freight Technologies Inc. and Freight App Inc. He brings to the company over 15 years of experience developing technology and digital marketing strategies, including serving as Country Manager for Osigu, Spain, and as head of AJEgroup’s IT division for the Asia-Pacific region. Prior to joining Fr8Tech, Mr. Selgas founded digital marketing agency Lanzadera Online. He has also served as an IT consultant to major corporations, including Endesa and Ibermatica.

Mike Flinker is President of Fr8Tech. He has over four decades of experience in the transportation industry, with 30+ years focused on cross-border logistics. Prior to joining Fr8Tech, Mr. Flinker founded FLS Transportation, the largest cross-border logistics company in Canada. He also previously held positions with Clarke Transport Inc., Canadian Pacific and Reimer Express Inc. (a division of Roadway Express).

Paul Freudenthaler is the company’s CFO and Secretary to the company Board. He has over 30 years of financial expertise, having previously served as CFO for several leading companies across multiple countries, including Macquarie in Mexico, Old Mutual in Latin America and Ascentium Capital in the U.S. Mr. Freudenthaler’s experience include leadership roles from which he guided IPOs and M&A transactions.

Luisa Lopez is COO of Fr8Tech. She brings to the company 25+ years of management experience in logistics, supply chain, operations and customer service. Ms. Lopez previously served as a Director of Landstar, where she was responsible for commercial and client development strategies in the Mexican market. Additionally, she managed more than 2,000 transport units specialized in staff and school mobility while with Traxion in Mexico.

Freight Technologies Inc. (NASDAQ: FRGT), closed Friday's trading session at $0.2925, off by 7.29%, on 2,080,037 volume. The average volume for the last 3 months is 2.08M and the stock's 52-week low/high is $0.1799/$3.60.

Recent News

Tingo Inc. (OTCQB: TMNA)

The QualityStocks Daily Newsletter would like to spotlight Tingo Inc. (TMNA).

The Super Bowl is one of the most viewed sporting events each yearglobally. Previously, crypto companies Coinbase and Crypto.comamong others would scramble to get even a single spot and spare nodime for an opportunity to advertise at the Super Bowl. However,the usual eye-catching cryptocurrency trading podium adverts were conspicuously absentduring the Super Bowl event this year. Last year, Larry David wasunamusing in the several old school outfits he spotted in an FTXadvert. Another ad had a crowd of people buzzing like bees in theair for eToro, and in yet another advertisement, a QR code bouncedaround the screen for the Coinbase crypto platform. But why wasthere no crypto ad in this year’s big game? In the monthssucceeding last year’s Super Bowl, the crypto industry had suffereda serious setback, especially FTX, which eventually filed forbankruptcy. The FTX suffered largely due to poor management offunds and poor liquidity that caused investors to panic andwithdraw suddenly. Industry players such as Tingo Inc. (OTC: TMNA) have had to dig deep and be resilient amid the storm that batteredthe industry in recent times. There is now relative calm and signsof recovery in the works for the industry.

Tingo Inc. (OTCQB: TMNA) is a digital service agri-fintech technology company focused on foundation-level agriculture and related financial services in Africa. The company aims to be Africa’s leading agri-fintech player, transforming rural farming communities to connect through its proprietary platform to meet their complete needs – from inputs and agronomy to off take and marketplace – and deliver sustainable income in an impactful way. The company’s vision is to build complete digitally inclusive ecosystems that promote financial inclusion and deliver disruptive micro-finance solutions, empower societies, produce social upliftment in rural communities and open international opportunities.

Tingo believes that a truly connected world will help contribute to a better global society. The company’s core focus areas are telecoms, financial services/fintech and agritech. Tingo’s goal is to provide a best-in-class customer experience, support the domestic economies of its host countries and support technological and financial inclusion to end the poverty premium. Through this, Tingo hopes to deliver attractive returns to shareholders while investing in the long-term future of the company and its subsidiaries.

Global climate change is challenging sustainable production and food security. Tingo’s strategy and market execution provide an opportunity for Africa to be a core focal point to solve a number of key areas of concern, including food security, gender equality, financial inclusion and poverty alleviation, to name a few. Disruption of micro finance through the use of DeFi-based stable coins and smart contracts will give agri-communities access to capital markets-driven digital finance solutions that make them more competitive and sustainable economically, striking a good balance of returns between digital asset providers and Tingo as the service partner. This innovation will deliver significant access to much needed finance at ‘Grassroot’ levels, delivering tangible social upliftment and GDP growth in the African markets served by Tingo.

Tingo Mobile, with more than nine million subscribers, is Nigeria’s leading technology and device-as-a-service platform aimed at accelerating digital commerce, especially in the country’s agritech and fintech verticals. The company helps farmers acquire mobile phones through a unique leasing plan, connecting them to mobile and data networks through its own virtual mobile network. Tingo also connects farmers to markets, services and resources via Nwassa, its digital agritech marketplace platform that commenced operations in 2020. The company has also launched a beta version of TingoPay – a B2B and B2C fintech app aimed at providing financial services to users inside and outside of the agriculture value chain. Among the services offered are mobile wallets, payment processing and access to specialist lenders, insurers and pension products.

Tingo will soon announce its innovative blockchain-based solution for use of digital stable coins to empower frictionless trade across borders in Africa. The company’s market-proven model in Nigeria is its core foundation, enabling Tingo to deliver the same service model across Africa to become the continent’s leading agri-fintech business powered through smartphone technology.

The African Continental Free Trade (ACFT) plan will be a key framework to prepare the company to be the leading intra-Africa trading hub for trade flows across Africa in the medium term, when it is likely the agreement will be executed into tangible activity. Tingo is well positioned to easily transform the goals of the ACFT into reality when finally implemented by the African Union and the various African countries that have not signed up.

Tingo posted total revenue of $594 million in 2020, with $212 million EBITDA. As of December 31, 2020, Tingo has 9,344,000 subscribers. The company is confident that these figures will grow through its expansion across Africa and natural progression of business in Nigeria.


Tingo has four core businesses:

  • Mobile Phone Leasing – Tingo has distributed almost 30 million mobile handsets since 2014 and will continue to replace the devices of its installed customer base every three years. Tingo Mobile provides the latest mobile phone handsets at an affordable price point and allows customers to spread payments over 36 months.
  • Mobile Voice and Data Service – Through a mobile virtual network, Tingo provides its customers with voice and data services, allowing customers to communicate effectively, both inside and outside the agricultural ecosystem.
  • Nwassa Marketplace Platform – Nwassa is Tingo’s proprietary agritech platform which provides Africa’s farmers with access to global markets to secure more competitive pricing for their crops. The platform processes 500,000 daily transactions with a value of over $8 million. A select group of trusted partners can assist smallholder farmers and agricultural cooperatives with packaging, warehousing, and dry and wet cargo logistics, as well as up-to-date information from the global agricultural sector. Tingo provides its customers with digital wallet services, which enable them to send and receive domestic payments, monitor cash flow in real time and securely hold money. The company also provides access to other services, such as utility bill payment, virtual airtime top-up, insurance services and alternative lending solutions.
  • TingoPay – Since the launch of the Nwassa platform, Tingo has been a dominant player in the B2B fintech vertical. After many successful months of operating Nwassa, Tingo entered the fintech B2C vertical to extend its B2B offering to a broader market beyond agriculture.

TingoPay is still in its beta phase and will launch in 2021 with a comprehensive marketing campaign. TingoPay offers the following services:

  • Tingo Wallet top-up
  • Peer to Peer payments, inclusive of merchant payments at the stores
  • Utility payments – airtime, broadband, cable, electricity, water, hotel, flights etc.
  • Pension payments
  • QR code payment services

Market Opportunity

Africa is the second-largest continent by population. It is also the youngest by far, with a median age of 18 for its 1.3 billion people. Tingo believes the building blocks for growth in Africa’s agriculture industry are in place and that the company is well positioned to participate in the upside. Sub-Saharan Africa’s population is growing at a rate of 2.7 percent per year. At the current growth rate, the continent’s population will double by 2050. Africa’s youthfulness represents a significant opportunity for material growth in demand for agricultural commodities. This younger generation is also being born into a digital world and is comfortable using technology.

Africa’s governments are improving business conditions for entrepreneurs and small businesses. Sub-Saharan Africa’s World Bank Doing Business rank has improved from 45 in 2004 to 65 in 2020. Tingo believes this trend will continue and encourage establishment of more new ventures across all economic sectors, including agriculture.

Africa attracted $407 billion of Foreign Direct Investments (“FDI”) between 2014 and 2018. Investments are increasingly focused on services and industrial sectors. Only 20 percent of investments are in extractive industries – a clear reversal from 2008, when 55 percent of FDI was aimed at resource extraction. Tingo believes FDI into Africa will help resolve significant infrastructure constraints and create value for agribusiness.

Management Team

Dozy Mmobuosi is the CEO of Tingo. He cofounded Tingo Mobile PLC (Nigeria) in 2001 and led the design and launch of Nigeria’s first SMS banking solution, which is still in use in the country today. He also headed a team of more than 120 Chinese and Nigerian engineers in the construction of two mobile phone assembly plants in Nigeria, which have produced and distributed 20 million phones across the country. He has led Tingo’s growth to more than $600 million in revenue annually. He holds a Ph.D. in Rural Advancement from UPM Malaysia.

Dakshesh Patel is the CFO of Tingo. He was formerly CFO of NatWest’s Global Debt and Investment Banking division. He has served as a Director at Gerken Capital Associates, a San Francisco-based alternative asset fund manager. He also led the restructure of Lloyds Banking Group (last financial crisis); managed integration of two leading shipping groups’ global treasury function to create world-leading shipping group Maersk Shipping; built three fintech companies; and exited one to Worldpay. Mr. Patel has strong banking experience, with a focus on Africa. He is a chartered accountant.

Chris Cleverly is president of Tingo. He has served as CEO of the Made in Africa Foundation, and as CEO of blockchain payments gateway startup Kamari. He has been a board member of several companies, both public and private, in the UK, India, China and Africa. He has advised multiple UK companies on their entrance into African markets, and regularly advises the UK Government on development issues and African governments on investment issues.

Clarence Simms is the Chief Technology Officer at Tingo. He has 25 years of IT and IT management experience. He has worked in IT Shared Services Technical Operations and IT Program Management for Huawei Technologies and MTN. As an entrepreneur, he created, a service that allows African Diaspora travelers to send airtime, pay bills, send mobile money and transfer money to a bank account from anyplace in the world.

Rory Bowen is the Chief of Staff at Tingo. Mr. Bowen started his career in traditional capital and derivatives markets working for Moneycorp and Tradition UK in European and emerging markets across FX, interest rate derivative and government bond markets. He has also spent time with one of Europe’s fastest growing fintech’s banking circles. Before joining Tingo, he was Chief of Staff at FinTech Alliance, an organization established in partnership with the UK Government Department for International Trade to foster innovation, growth and foreign direct investment (FDI) in the financial services sector and facilitate greater public/private cooperation.

Tingo Inc. (OTCQB: TMNA), closed Friday's trading session at $0.28635, off by 10.5156%, on 26,005 volume. The average volume for the last 3 months is 26,005 and the stock's 52-week low/high is $0.01/$5.99.

Recent News

Hillcrest Energy Technologies Ltd. (CSE: HEAT) (OTCQB: HLRTF) (FRA: 7HIA.F)

The QualityStocks Daily Newsletter would like to spotlight Hillcrest Energy Technologies Ltd. (OTCQB: HLRTF).

Hillcrest (CSE: HEAT) (OTCQB: HLRTF), a developer of next-gen technologies for EV powertrains andgrid-connected renewable energy systems, remains committed tobuilding momentum gained in 2022. “As the previous year drew to aclose, this developer of transformative power conversiontechnologies and control system solutions for modern electricalsystems validated its zero-voltage switching (‘ZVS’) invertertechnology for the EV market that the company intends to use as thelaunchpad to accelerate its building-block product developmentapproach. After laying the groundwork for success in 2022,Hillcrest now eyes ambitious technology development milestones in2023, including completing several proof-of-concept tests forsolutions the company has been developing, such as a grid-tiedinverter, enhanced powertrain solution and novel multi-levelinverter technology,” a recent article reads. “In 2023, Hillcrestexpects its diversified intellectual property (‘IP’) portfolio togrow and mature, boasting proprietary firmware and four hardwarepatent applications. With technical experience and expertise thattranscends what most companies possess at that stage and a robustIP foundation, Hillcrest appears to have created a powerfulfoundation that will continue to advance over the coming year.” Toview the full article, visit

Hillcrest Energy Technologies Ltd. (CSE: HEAT) (OTCQB: HLRTF) (FRA: 7HIA.F) is a clean technology company based in Vancouver, British Columbia, engaged in developing high-value, high-performance power conversion technologies and digital control systems for next-generation powertrains and grid-connected renewable energy systems.

From concept to commercialization, Hillcrest invests in the development of energy solutions that power a more sustainable and electrified future. Hillcrest power inverter technology helps produce efficiencies in electrification and maximize the performance of electric systems, including electric vehicles (EV), motors and generators.

The company offers a flexible, single-inverter architecture that can be applied at nearly every stage of the electrification ecosystem, from renewable energy generation through the charging and operation of an EV, to provide full-cycle efficiency and performance improvements.

As momentum to electrify and decarbonize energy systems accelerates, Hillcrest believes the power inverter is increasingly emerging as a key component. While system cohorts such as battery packs, PV panels and electric motors are often in the spotlight, the inverter holds the key to unlocking efficiency and performance improvements.

Hillcrest power inverter technology is:

  • REVOLUTIONARY: high-efficiency inverter technology has the potential to revolutionize how motors respond and how efficiency is gained.
  • AGILE: able to deliver and deploy high-efficiency inverter solutions purpose-designed to meet specific customer needs.
  • INNOVATIVE: technology-forward, clean-energy experts who are focused on advancing and optimizing efficient alternative energy use across all electric vehicle and charging platforms.
  • A MARKET LEADER: a next-generation technology provider to the automotive industry’s top suppliers and manufacturers.

Technology & Applications

Hillcrest’s first application for its inverter technology – a 250 kW|800V Hillcrest SiC high efficiency traction inverter – is focused on the growing EV market. Hillcrest technology eliminates traditional design trade-offs faced across the power industry – deploying higher switching frequencies has historically meant a greater increase in losses, lower system efficiency and higher heat. Through a combination of hardware and software expertise, Hillcrest enables power applications to leverage higher switching frequencies AND

  • Realize improved power system performance and reliability
  • Operate at higher power levels without compromising efficiency

The expected benefits of Hillcrest’s traction inverter have been confirmed via testing and shared in a technical white paper, published in April 2022, that confirmed the following results:

  • Significant efficiency gains – 99%-plus inverter efficiency
  • Increased power density targeting 50kW/L+
  • Significantly increased motor efficiency
  • Lower stress on mechanical and electrical parts, enhancing reliability
  • Improved thermal management

Hillcrest has also filed a patent for an enhanced powertrain solution that offers the potential to simplify EV charging and redefine how the industry envisions charging infrastructure. The company believes the most exciting benefit of the enhanced powertrain solution is the ability to eliminate the onboard charger and booster from an EV, as well as faster, anywhere charging including direct DC, wireless, and bidirectional charging across current and future power levels. Hillcrest sees this as a true EV charging game changer.

The company’s technology applies to nearly every clean energy industry segment:

  • Wind power – an inverter is deployed at a wind turbine generator to convert the AC output, with at least one additional inverter used to deliver the power to the grid/battery.
  • Solar power – an inverter is used to convert the DC output from the photovoltaic panels into the AC power that flows to the grid/battery/home.
  • Energy storage – an inverter is deployed to convert the DC output from the storage system or batteries to the AC power that flows to the grid/home/EV.
  • EV fast chargers – an inverter converts the AC input from the grid/storage system to the DC output needed to charge an EV’s battery.

Market Outlook

According to an April 2022 market analysis by Vantage Market Research (VMR), the global power inverter market is expected to reach a value of $95 billion by 2028, driven by increasing demand for EVs, energy generating wind turbines and solar-powered photovoltaic systems. That jump is forecast from an estimated $70.5 billion market value in 2021 and represents a compound annual growth rate of more than 5%.

According to the VMR report, many governments in countries around the world are supporting alternative options for efficient and nonpolluting energy generation. This has boosted demand for wind energy and solar energy systems. Hillcrest is aiming to capture a share of this future market growth across nearly every segment of the clean energy industry.

Management Team

Don Currie is the founding CEO of Hillcrest Energy Technologies. He has led the company’s successful transition from fossil fuels into clean energy technologies. Earlier in his career, he held various senior level positions, including director, officer and vice president of corporate communications with Enhanced Oil Resources Inc., an oil and gas exploration and production company based in Houston. Prior to that, he worked in other private and public ventures spanning the mining, gaming and technology sectors.

Jamie L. Hogue is the COO of Hillcrest. She brings more than two decades of progressive policy leadership, economic analysis and organizational development experience to Hillcrest. She builds collaborative processes and solutions that drive growing organizations toward a more resilient future. She previously served as the director of operations for Arizona State University’s Ten Across initiative – a compelling observatory positioned on the front lines of economic, social and climate change. She earned a master’s degree in public administration and a bachelor’s degree in economics from Arizona State University.

Ari Berger is Chief Technology Officer at Hillcrest. He brings over a decade of commercial experience with a track record of deploying new electrification technologies and go-to-market strategies. In 2015, he founded NIG Systems Ltd. in Israel, which specializes in custom high performance control systems design. Prior to this, he previously worked for Bental Industries, a leading motor manufacturer. He holds a master’s degree in system control engineering from the Technion – Israel Institute of Technology.

Raj Clair is CFO at Hillcrest. She is a CPA who began her career at Deloitte and has served in advanced finance positions in the energy and resources sector. She has been responsible for reporting, audits and internal controls, as well as working on budgeting and forecasting. She has worked with various publicly listed companies, including SEC registrants, and has both Canadian and U.S. experience. She holds a bachelor’s degree in accounting from Simon Fraser University.

Hillcrest Energy Technologies Ltd. (NASDAQ: HLRTF), closed Friday's trading session at $0.06525, off by 0.153022%, on 34,550 volume. The average volume for the last 3 months is 34,550 and the stock's 52-week low/high is $0.0584/$0.1468.

Recent News

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers

The QualityStocks Sponsored News

The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal

The QualityStocks Sponsored News

The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal

The QualityStocks Sponsored News

The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.